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1  |  INTRODUC TION
Rapid, reliable and easy access diagnostics can significantly improve 
early detection and treatment monitoring of high mortality diseases, 
such as cardiovascular diseases, cancer, diabetes, among others 
(Rebelo et al., 2019). The successfully diagnostics of a disease, even 
prior to the manifestation of any symptom, can be crucial to effi-
cacious treatment and survival rate (Chamorro-Garcia & Merkoçi, 
2016).
Biomarkers are frequently used to diagnose these diseases; how-
ever, they need to be quantified in a specific concentration range in 
physiological fluids, such as blood and urine, which is a time-consum-
ing process that uses bulky and expensive laboratory equipment. 
Thus, there is a need for portable, rapid and reliable technologies 
that can simplify laboratory biomarker quantitation (Wu et al., 
2017). In order to achieve this, a plethora of sensing mechanisms 
have been combined with biological elements, producing biosensor 
technologies, which enable the quantitation of analytes in mixtures. 
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Current diagnostics present challenges that are imposed by increased life expectancy 
in the worldwide population. These challenges are related, not only to satisfy the 
need for higher performance of diagnostic tests, but also to the capacity of creating 
point-of-care, wearable, multiplexing and implantable diagnostic platforms that will 
allow early detection, continuous monitoring and treatment of health conditions in 
a personalized manner. These health challenges are translated into technological is-
sues	that	need	to	be	solved	with	multidisciplinary	knowledge.	Nanoscience	and	tech-
nology play a fundamental role in the development of miniaturized sensors that are 
cheap, accurate, sensitive and consume less power. At nanometre scale, these materi-
als possess higher volume-to-surface ratio and display novel properties (composition, 
charge, reactive sites, physical structure and potential) that are exploited for sensing 
purposes. These nanomaterials can therefore be integrated into diagnostic sensing 
platforms allowing the creation of novel technologies that tackle current health chal-
lenges. These nanomaterial-enhanced sensors are extremely diverse, since they use 
numerous types of materials, nanostructures and detection modes for a multitude 
of biomarkers. The purpose of this review is to summarize the current state-of-the-
art of nanomaterial-enhanced sensors, emphasizing and discussing the diagnostic 
challenges that are addressed by the different engineering and nanotechnology ap-
proaches. This review also aims to identify the drawbacks of nanomaterial-enhanced 
sensors, as well as point out future developmental directions.
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Biosensors are composed by a biological element, that will select 
the analyte from a mixture, a transducer, that transforms the signal 
resulting from analyte binding into something readable, and a reader, 
that shows the signal value (Mehrotra, 2016). Biosensors are usually 
classified according to their transducer nature into electrochemical, 
optical, piezoelectric, electronic and gravimetric (Leca-Bouvier & 
Blum, 2005; Liu & Jiang, 2017; Rebelo et al., 2019). Furthermore, all 
different types of biosensors present attributes such as sensitivity, 
accuracy, repeatability, precision or specificity that are measured 
during the optimization of a biosensor and reflect its performance 
(Rebelo et al., 2019; Turner, 2015; Figure 1). Although several bio-
sensing technologies have been reported in the last 10 years, only 
a few have been successfully commercialized, such as discussed in 
detail in Section 4.
In order to improve the limitations of current biosensors, they 
have been integrated with systems creating a plethora of lab-on-
chip miniaturized diagnostic device platforms for point-of-care and 
multiplex	biomarker	quantification	(Liao	et	al.,	2018).	One	such	de-
vice is microfluidics enables the processing of very small sample vol-
umes (pL-nL) in short times (min or s), improving the performance of 
diagnostic tests (Barbosa et al., 2018).
However, the demand for wearable and implantable technolo-
gies imposes new approaches that go beyond lab-on-chip devices 
(Barbosa	&	Reis,	2017;	Rebelo	et	al.,	2019).	Nanotechnology	allows	
the next level of miniaturization of bioanalytical systems, by inte-
grating sensors, fluidics and signal-processing circuits, which can 
provide the large-scale integration of different biochemical reac-
tions on a smaller footprint (Vashist et al., 2012; Zhang et al., 2009), 
contributing for biosensors to achieve current society healthcare 
needs.	 Nanomaterial-enhanced	 sensors	 are	 analytical	 devices	 ca-
pable of detecting a target analyte from a biological sample (blood, 
tissue, saliva, urine, etc. taken from a person), that integrate nano-
material as a strategy for improving biosensors features. Materials 
at nanoscale have been shown to exhibit properties that are vastly 
different from the bulk material from which they are derived. Their 
small size, large surface area-to-mass ratio and high reactivity impart 
characteristics that provide biosensors with unique capabilities.
This review intends to present the current state-of-the-art of 
nanomaterial-enhanced sensors, discussing how these nanoma-
terials can address the current technological challenges in clinical 
diagnostic biosensors. The limitations and future directions of nano-
material-enhanced sensors are also explored.
2  |  NANOMATERIAL-ENHANCED 
SENSORS FOR CLINIC AL DIAGNOSTIC S—AN 
OVERVIE W
Nanomaterial-enhanced	 sensors	 are	miniaturized	 devices	 that	 use	
nanotechnology for improving the quantification of molecules 
within a mixture using specific immobilized receptors and trans-
ducers capable of transforming a physical–chemical mechanism 
into a readable signal. These sensors aim to tackle current diagnos-
tic challenges in terms of performance, point-of-care applications, 
wearable/implantable capacity and multiplex monitoring (Figure 1). 
Nanomaterial-enhanced	sensors	present	several	advantages,	when	
compared with macro scale sensors. These include low production 
cost due to miniaturization, high portability, lower-power consump-
tion, high surface area and large pore volume per unit mass, high 
tunable size and shape-dependent characteristics and unique and 
tailorable surface chemistry. These unique properties, which can be 
achieved by the use of nanomaterial, lead to enhanced specificity 
and sensitivity of the biosensor, essential for clinical diagnosis since 
the concentration of biomarkers in blood is a millionth compared to 
the concentration of other blood proteins.
Nanomaterial-enhanced	 sensors	 can	 be	 produced	 by	 several	
techniques, being the most common top-down lithography, bot-
tom-up fabrication and self-assembled nanostructures (Biswas et al., 
2012). These fabrication techniques are combined with different 
approaches for nanomaterial synthesis, such as layer-by-layer, sput-
tering, emulsion, ball mixing and electrochemical (Malhotra & Ali, 
2018). Therefore, several nanomaterial with unique electrical, op-
tical, electrochemical and thermal properties have been developed 
to detect biomarkers with improved performance (Hou et al., 2016). 
Among	those,	nanoparticles	(NPs),	nanowires	(NW),	nanofilms	(NF),	
quantum	dots	 (QDs),	nanocrystals	 (NC),	nanorods	 (NR),	nanobelts,	
nanotubes	 (NTs)	 embedded	 nanostructures	 and	 self-assembled	
nanomaterial stand out. Figure 2 represents several shapes of nano-
material according to their dimensions. The exploration of these 
nanostructures with different functionalities is crucial for biosensor 
developments.
Nanomaterial	is	generally	integrated	in	sensors	to	enhance	their	
output signals. Their type and structure will depend on the trans-
ducing mechanism. The specific analyte receptors can be directly 
immobilized on a surface by adsorption (Baby et al., 2010; Qin 
et al., 2012), by covalent attachment (Song et al., 2011), or encap-
sulation within a coated layer of a permeable conductive polymer, 
or by using a cross-linking reagent (Gao et al., 2010; Janegitz et al., 
2015; Liu et al., 2012; Unnikrishnan et al., 2012). In electrochemi-
cal sensors, a chemical reaction occurs between the receptor and F I G U R E  1 Challenges	in	diagnostic	biosensors
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analyte producing the release, acceptance or consumption of ions. 
This generates a signal such as an electrical current or potential, and 
the magnitude of the change in the signal can be used to quantify 
the presence and concentration of the analyte/biomarker. There are 
many types of electrochemical detection techniques: potentiometry, 
voltammetry, impedance spectroscopy and conductometry. For ex-
ample, field-effect transistors (FETs) use potentiometry to measure 
ions	present	 in	the	gate	electrode	area	of	the	FET	(Figure	3).	NW,	
with cross section in the nanometre scale and a length-to-diameter 
ratio in the range of >1000 nm, have been used has transducers for 
FET detection. FET-based devices are composed of source, drain 
and	gate	electrodes.	Most	NW	are	made	of	silicon	which	rely	on	its	
semiconductor properties and is synthesized through bottom-up 
or top-down approaches (Biswas et al., 2012). The semiconductor 
nanowire bridges the source and the drain, while the gate electrodes 
modulate the conductance of the channel. FET sensors operate in 
the	fM	and	nM	range	 (Patolsky	et	al.,	2006;	Zhang	&	Ning,	2012).	
Sensitivity	can	be	increased	by	reducing	the	diameter	of	the	NW	(Li	
F I G U R E  2 Classification	of	nanomaterial	according	to	their	dimensions	(Malhotra	&	Ali,	2018).Figure	adapted	with	permission	from	
Elsevier
F I G U R E  3 Schematic	of	a	biological	and	chemical	FET	sensor	(Kaisti,	2017).	Figure	adapted	with	permission	from	Elsevier
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et	al.,	2005),	controlling	doping	density	(Nair	&	Alam,	2007).	Further	
increases in sensitivity can be achieved by changing the method of 
detection (Rajan et al., 2013) (Ermanok et al., 2013) (Gao et al., 2010). 
The research group of CM Lieber (Gao et al., 2010, 2015; Patolsky 
et al., 2006; Patolsky et al., 2006; Zheng et al., 2005) were one of 
the	first	to	use	SiNW	for	detection	of	biomarkers.	They	were	able	to	
detect concentrations in the range of pM to fM range. Their devices 
also allowed the detection of multiple protein markers. Multiple 
NW	were	deposited	in	a	single	device	(Figure	3)	and	functionalized	
for different protein markers, thus making these devices versatile. 
Carbon	nanotube	(CNT)	NW	has	also	been	used	for	FET	detection	
(Kong	et	al.,),	but	show	a	lower	detection	limit	(in	pM)	than	their	sil-
icon	 counterparts.	 Nanowire	 sensors	 (Patolsky	 et	 al.,	 2006)	 have	
been demonstrated to detect cancer-associated in analytes in blood, 
tumour tissues and exhaled breath of cancer-infected patients 
(Shehada et al., 2015).
In optical biosensors, the reaction between the analyte and the 
receptor produces luminescence due to electromagnetic excitation 
at optical frequencies. Sensitivity is dependent on the detection 
mode such as fluorescence, Raman Spectroscopy, Surface Enhanced 
Raman scattering (SERS), refraction and others. Biological moieties 
attach to nanostructures affecting their light emitting characteris-
tics. Changes that occur due to molecular binding affect the exci-
tation of nanomaterial. This phenomenon can be exploited to detect 
an analyte of interest. For instance, surface plasmon resonance 
(SPR) sensors measure the change in refractive index of the medium 
at the sensing surface due to the binding of the molecules. There 
are two types SPR sensors: propagating SPR (PSPR) sensors and lo-
calized SPR (LSPR) sensors (Mulvaney, 2011; Figure 4). Both PSPR 
and LSPR have detection limits of less than 1 pm. Gold nanoparticles 
(AuNPs),	often	referred	to	as	plasmonic	NPs,	are	used	to	improve	the	
sensing performance of LSPR sensors (Anker et al., 2008; Haes et al., 
2005).	 These	NPs	 are	 signal	 producers,	 exhibit	 strong	 absorption	
in	 the	visible	and	near	 infrared	 (NIR)	wavelength	regions	and	gen-
erate large electric fields due to LSPR on the surface of the par-
ticles (Swierczewska et al., 2012), increasing the sensitivity (Burda 
et al., 2005). The sensors require uniform nanomaterial to produce 
a narrow LSPR peak. A shift in the peak occurs when a biomarker 
attaches. Shifts in LSPR peak can be detected by absorption spectra 
in the visible light region by using colorimetric technique.
The colour of the particles is affected by the size and shape of 
the	material	 and	 their	dielectric	 constant.	AgNPs	displayed	better	
sensing	performance	compared	to	AuNPs	because	of	its	higher	di-
electric	 constant.	 Aggregation	 of	 NPs	 enhances	 sensitivity	 by	 in-
creasing the absorption coefficient. This makes the use of magnetic 
NPs	 an	 attractive	 choice	 (Elghanian	 et	 al.,	 1997;	 Lee	 et	 al.,	 2011;	
Medintz	et	al.,	2005;	Nie	&	Emory,	1997;	Qian	&	Nie,	2008;	Qian	
et	al.,	2008).	AuNPs	are	the	most	widely	used	in	SPR-based	sensors	
as they are easy to synthesize and functionalize with various biolog-
ical	molecules.	Furthermore,	AuNPs	with	many	biologically	attached	
functional groups or antibodies have shelf life of around 18 months 





from latex (Mosier-Boss, 2017; Zeng et al., 2014) and liposomes 
(Lum	et	al.,	2017;	Zeng	et	al.,	2014).	Nanotechnology	has	enabled	
the ultrasensitive detection of biological analytes using SPR sensing 
techniques.
Another optical detection strategy often used in nanomateri-
al-enhanced sensors is fluorescence and other forms of lumines-
cence. QDs exhibit useful properties for fluorescence sensing and 
labelling. A quantum dot is arranged in binary (e.g. CdSe, CdTe, GaAs, 
InAs, SiC) or ternary compounds (e.g.	InGaN,	InGaP,	InGaAs)	consist-
ing of few hundred to thousands of atoms with size ranging from 1 
to 20 nm (Guzelian et al., 1996). They display properties interme-
diate between bulk semiconductors and discrete atoms, and their 
properties depend on their size and shape (Allen & Bawendi, 2008; 
Bruchez	 et	 al.,	 1998;	Kairdolf	 et	 al.,	 2008;	Chan	&	Nie,	 1998;	Xie	
et al., 2007). The shift in energy level, otherwise (increase in the QD 
band	gap),	 increases	as	 the	QD	size	decreases	 (Norris	&	Bawendi,	
1996;	Norris	et	al.,	1994,	1996).	Larger	diameter	sized	QD’s	(5–6	nm)	
emit	longer	wavelengths,	while	smaller	diameter	sized	QD’s	(2–3	nm)	
emit shorter wavelengths, though the specific colour emitted is af-
fected by their composition. A comparison of QDs to the traditional 
fluorophore's is discussed in details elsewhere (Resch-Genger et al., 
2008). QD have several advantages over conventional dyes as they 
have high brightness, good photostability, a broad spectrum of ex-
citation and long fluorescence lifetime (Jaiswal et al., 2003; Resch-
Genger	 et	 al.,	 2008).	 NIR	 (near	 infrared)	 (650–1350	 nm)	 emission	
is highly desirable for biomedical imaging due to its reduced light 
scattering and low tissue absorption. This has prompted researchers 
to	make	use	of	the	NIR	optical	window	to	conduct	deep-tissue	op-
tical imaging and sensing with the aid of QD, which are essentially 
zero-dimensional nanomaterial. QD can be synthesized in non-polar 
F I G U R E  4 Diagrams	showing	the	sensing	principle	of	the	
studied SPR (left) and LSPR (right) systems. The graphs display the 
calculated shift of dip/peak upon adsorption of different thickness 
molecular film with an refractive index of 1.48 in water (Jatschka 
et al., 2016). Figure reproduced with permission from Elsevier
    |  5 of 38BARBOSA et Al.
solvents (Crouch et al., 2003; Murray et al., 1993), aqueous solu-
tions (Alivisatos,) or on a solid substrate (Bhattacharya et al., 2004). 
Their excellent fluorescent properties make them an outstanding 
fluorescence resonance energy transfer (FRET) donor. The bright-
ness makes them attractive for sensors with high sensitivity, and 
their photostability enables repetitive imaging applications (Chen & 
Periasamy, 2006; Shi et al., 2015). QDs can also be designed with 
nanoscaffold purposes. They present a large surface area as solid 
substrate for molecule adsorption, and multiple acceptors that can 
be conjugated to a single QD, allowing signal amplification and sen-
sitivity increment (Resch-Genger et al., 2008). QD form a core-shell 
structure, for example CdSe (Cadmium selenide) QD with ZnS (Zinc 
sulphide) shell, which enhances QD luminescence by improving its 
quantum yield and narrowing the emission spectrum, minimizes the 
toxicity of core materials by preventing leach outs.
Mechanical sensors detect forces and deflection due to mass 
changes caused by the adsorbed analyte. These mass variations 
can be transduced by frequency, temperature and stress discrep-
ancy. For example, the attachment of an analyte to a sensor can be 
studied using cantilevers. These cantilevers can be integrated in 
microelectromechanical system (MEMS) or nanoelectromechani-
cal	 systems	 (NEMS).	MEMS-based	 devices	were	 initially	 based	 on	
solid-state semiconductor like silicon (Doll et al., 2009; Park et al., 
2010; Villanueva et al., 2008) and its derivatives like silicon nitride 
(Hyun et al., 2006; Venkatasubramanian et al., 2012) and silicon di-
oxide (Huang et al., 2013; Yang et al., 2008). Because of clean room 
requirements and large initial equipment costs, alternate materials 
with matching performance but reduced material and fabrication 
costs were sought after. In this respect, synthetic polymers are an 
attractive choice. Various polymers such as parlene, polypropyl-
ene, SU-8, fluoropolymer, polyethylene terephthalate, polystyrene 
and others have been explored to realize miniaturized devices, and 
studies highlighting the optimal performance of cantilever sensors 
based on structural characteristics and material selection have been 
reported (Mathew & Ravi Sankar, 2018). Cantilever-based sensors 
are classified as surface stress-based sensors (due to cantilever 
beam deflection or static mode), dynamic-mode based sensors (due 
to change in resonant frequencies) and bimetallic mode based sen-
sors (due to change of thermal expansion of cantilever metallic layer) 
(Figure 5).
When an analyte binds, it adds mass to the device and devel-
ops a surface inducing deflection of the cantilever. The deflection 
can be quantified by optical methods such as laser beam deflec-
tion (Figure 6), though electrical readout has also been employed 
(Backmann et al., 2005; Fritz et al., 2000; Mertens et al., 2008; Wu 
et al., 2001; Zhang et al., 2006). Using optical methods, the resolu-
tion of cantilever deflection is in nanometres (Binnig et al., 1987) 
and mass detection sensitivity is in pictogram (Chen et al., 1995). In 
the dynamic-mode method, the sensor oscillates with resonance fre-
quency, and this frequency changes when a mass is attached to the 
cantilever. The dynamic-mode method is less sensitive and can lead 
to erroneous result due to the damping effect of the fluid. When 
detection in static mode is made using piezoresistive readout, the 
performance of the device can be enhanced by amplifying the stress 
generated by cantilever bending, thus improving electrical sensitiv-
ity (Ansari et al., 2012).
In mechanical sensors, it is generally desirable to reduce the di-
mensions of the device, since nanoscale increase mass resolution. 
The ability of devices to be displaced or deformed greatly increases 
with a reduction in its dimensions. There are several challenges in 
miniaturizing these cantilever-based sensors. Detection using opti-
cal	means	becomes	difficult	as	device	dimensions’	scale	below	op-
tical wavelength. Also, sensitivity using electrostatic detection and 
piezoresistive devices decreases at nanoscale, not only due to de-
tection modes, but also due to other interfering factors that are en-
hanced at nanoscale. For example, the non-specific binding of other 
species rather than the target analyte is amplified at nanoscale, re-
sulting in most of the sensor interactions and increasing the possibil-
ity of error by introducing noise in the data. Thus, the detection limit 
and sensitivity is not only depended on the sensor design, but also 
F I G U R E  5 Cantilever	sensor	operation	mode:	(a)	detecting	mass	variations	on	the	cantilever	by	deviations	in	resonance	frequency;	(b)	
bimetallic mode detecting temperature variations by a static bending; and (c, d) surface stress mode, where asymmetric molecular binding 
to the cantilever's top or bottom surface leads to an overall cantilever bending. For example, adsorption on the top surface can either 
cause tensile stress (c), bending the cantilever upwards, or compressive stress (d), bending the cantilever downwards (Fritz, 2008). Figure 
reproduced with permission from The Royal Society of Chemistry
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in other factors, related to diagnostic assays (Swierczewska et al., 
2012).
The particular combination of sensors materials, fabrication 
technologies and detection modes will dictate which diagnostic 
current challenges can be addressed and therefore the medical 
application of the biosensors. Different nanomaterial-enhanced 
sensor approaches can be taken in order to improve the diagnostic 
performance or add point-of-care, wearable and implantable diag-
nostic features. For example, the effect of graphene in vivo appli-
cations depends on how the graphene was synthesized and purified 
(Pinto et al., 2013). Therefore, for wearable and implantable sensors, 
graphene nanomaterial production process needs to follow specific 
criteria. Graphene high conductivity, electrochemical stability and 
flexibility make this material an ideal candidate for biosensors with 
electrochemical and optical detection modes. Graphene microelec-
trode arrays and graphene field-effect transistors have been used 
for neural stimulation (Thunemann et al., 2018). Wet-spun reduced 
graphene oxide have been used for free-standing penetrating elec-
trodes (Apollo et al., 2015).
The combination of different nanomaterial with particular nano-
structures in sensor devices and the interaction of these nanoma-
terials with specific detection modes will produce biosensors with 
unique features capable of addressing current clinical diagnostic 
needs.
3  |  CURRENT DIAGNOSTIC CHALLENGES: 
NANOMATERIAL-ENHANCED SENSORS 
APPROACHES
Biosensors are promising tools for clinical diagnostics; however, they 
still face current technical challenges (Figure 1) that pushes them 
away from becoming a reality and serving the worldwide population 
healthcare needs. These challenges are the improvement of diag-
nostic performance, the capacity for multiple detection, the pro-
duction of point-of-care quantitative devices and the production of 
wearable and implantable technologies for biomarkers detection. 
Several strategies have been reported that integrate nanomaterial 
in biosensors, providing some insights in how these challenges can 
be solved. Table 1 presents the state-of-the-art of nanomaterial-en-
hanced sensors in clinical diagnostics, with reported literature from 
2017 to present, and provides a clear connection to which technical 
challenge is being addressed by the nanotechnology approach. The 
discussion and exploration of Table 1 are done along Section 3 of 
this review.
3.1  |  Nanomaterial for diagnostic 
performance demands
In general, a diagnostic test measures a specific analyte in complex 
samples, such as blood, urine or saliva. In order for the technology 
to be successful, the test needs to be sensitive, have a low detection 
limit, have a wide dynamic range, be precise and accurate (Figure 7). 
These performance parameters are essential for accurate diagnos-
tics and subsequent clinical treatment decisions. Therefore, finding 
ways to overcome current diagnostic technologies performance is 
one	of	the	main	challenges	in	the	biosensors	field.	Nanotechnology	
has for sure given great contributions towards performance im-
provement in biosensors as described below.
Of	all	the	parameters	mentioned	above,	the	sensitivity	and	de-
tection limit are the most frequently cited parameters of interest in 
biosensors literature. These two parameters are at times used inter-
changeably; however, they are different terms, and it is important 
to understand their differences. Analytical sensitivity, a term that 
is indicative of the capacity of the method to differentiate between 
two very close signal points, is usually given by the slope of the cal-
ibration curve. The detection limit, on the other hand, describes the 
minimum signal that a device/test can quantify with a specified pre-
cision and reproducibility (Armbruster & Pry, 2008; Barbosa & Reis, 
2017; Shrivastava & Gupta, 2011).
Several nanomaterials have been used in different biosensor 
technologies to improve the analytical sensitivity of diagnostic tests 
and lower their detection limits. These are summarized in Table 1. 
These	nanomaterials	can	be	applied	in	different	manners,	like	NPs,	
nanocrystal, QDs, among others, depending on the biosensor detec-
tion	mode	and	biochemical	assay	involved.	Nevertheless,	in	general,	
nanomaterials enhance the efficiency of probe immobilization, due 
to their high surface area and chemistry (Barbosa et al., 2017, 2019), 
providing signal amplification, improving analyte-transducer contact 
and promoting efficient catalysis in case of electrochemical sensors. 
The combination of these effects enables the quantification of low 
analyte concentrations in assays with improved performance, which 
is highly desirable in diagnostics. References presented in Table 1 
and	several	published	reviews	(Kerman	et	al.,	2008;	Luo	et	al.,	2006;	
Wongkaew	et	al.,	2019;	Xu	et	al.,	2020;	Zhu	et	al.,	2015)	reveal	that	
F I G U R E  6 Optical	recognition	of	cantilever	deflection	(Lavrik	
et al., 2004). Figure reproduced with permission from AIP 
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engineered nanomaterials are attractive for sensing applications, as 
electrochemical biosensors, as their conductive properties can en-
hance catalysis and electron transfer. Table 2 summarizes the per-
formance parameters of nanomaterials enhanced sensors further 
discussed in this section.
3.1.1  |  Nanoparticles
Nanoparticles	 are	 by	 far	 the	most	 used	 nanomaterial	 in	 the	 field,	
due to their varied properties that can be easily tuned by changing 
parameters as size, shape and composition (Capek & Capek, 2006; 
Zamborini	et	al.,	2012).	NPs	provide	interesting	properties	for	sens-
ing applications like enhanced electrical conductivity, high reactivity, 
large surface area-to-volume ratio, improved optical effects, mag-
netic properties and quantum confinement effects. They are also 
easily synthesized in the laboratory or commercially available which 
facilitates their usage in research settings. 1D nanoscale structures 
have gained great attention due to their properties of high surface 
area-to-volume ratio, ultrasmall scale and important applications in 
nanoscale device generation. These structures are commonly used 
in microfluidic chips and sensing devices, since they provide several 
advantages over bulk approaches, like reduced sample needs, oper-
ate in the laminar flow regime in the microchannels and controlled 
self-assembly	of	nanostructures	(Xing	&	Dittrich,	2018).
Nanoparticles	 are	 used	 for	 high	 sensitivity	 and	 detection	 limit	
improvement in electrochemical diagnostic sensors. By increasing 
the surface area of the working electrode, there is an acceleration 
in the electron transfer at the electrode interface and an increment 
in the area available for probe immobilization (Barbosa et al., 2019). 
This increment in the surface area is usually translated in signal am-
plification, and therefore, lower biomarkers concentration can be 
detected. For instance, a working electrode made of screen-printed 
carbon	was	covered	with	electrodeposited	AuNPs	and	5,2′:5′2′′-ter-
thiophene-3′-carboxylic	 acid	 (TTCA).	This	 sensor	presented	excel-
lent analytical performance, quantifying cardiac troponin I (cTnI) with 
a dynamic range of 1–100 pM (0.024–2.4 ng/ml) and a detection limit 
of 1.0 pM (24 pg/ml), which is lower than the existing cut-off values 
(40–700 pg/ml). The chronoamperometric sensor performance is 
due	to	AuNPs	deposition,	that	increases	the	surface	area,	enabling	
a broad dynamic range, and TTCA deposition that allows immobi-
lization of biomolecules, in addition to exhibiting good electrical 
properties. This higher performance in cTnI detection is extremely 
useful since cTnI has shown high sensitivity and selectivity towards 
acute myocardial infarction (Jo et al., 2017). In another example, an 
electrochemical biosensor was developed for dopamine detection. 
Abnormal levels of dopamine are linked to Alzheimer's disease, de-
pression, Parkinson's disease, hyperactivity disorder and schizo-
phrenia.	The	developed	biosensor	consisted	of	AuNPs	supported	by	
graphene oxide functionalised by an ionic liquid coated onto a glassy 
carbon	electrode.	The	loading	of	AuNPs	significantly	enhanced	the	
catalytic performance of the sensor complexes measured with cy-
clic voltammetry, due to their excellent electron transfer properties 
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for the survival rate and recovery evaluation of stroke patients 
(Figure 9a). The biosensor performed in the range up to 100 ng/ml 
with a detection limit of 1 pg/ml, in unprocessed blood samples. The 
AgNPs	(Figure	9b)	shown	strong	enhancement	effects	from	individ-
ual particles due to their ability to localize the surface electromag-
netic	 fields	 through	 the	 hot	 spots	 in	 their	 structures.	 The	 AgNPs	
were modified with polyvinylpyrrolidone (PVP) to enhance stability 
which is more suitable for biological monitoring (Zhao et al., 2019). 
In	another	study	(Kong	et	al.,	2017),	positively	charged	amino-func-
tionalized	 SiO2NP’s	 worked	 as	 nanocapturer	 by	 electrostatically	
adsorbing	 PSA	 aptamer	 to	 form	 SiO2NP-aptamer	 nanocomposite	
which was capable of adsorbing negatively charged tetraphenyleth-
ylene derivative 3 (TPE3) to form aggregation-induced fluorescence 
emission-SiO2NPs	nanocomposite.
The binding of the aptamer to the target PSA resulted in the re-
lease	of	the	aptamer	from	the	surface	of	SiO2NPs,	which	made	the	
TPE3	aggregate	on	the	SiO2NPs	surface	thus,	emitting	high	fluores-




and depending on their chemical composition, they can offer con-
ductivity improvements. Existing screening procedures for prostate 
cancer in clinical practice are unable to detect low serum PSA levels. 
Nanowire-based	have	contributed	to	the	detection	of	protein	can-
cer markers (Gao et al., 2015; Puppo et al., 2016; Tzouvadaki et al., 
2016; Zheng et al., 2005). A real-time method for detection of PSA 
using	n-type	SiNW	FET	(silicon	nanowire	field-effect	transistor)	bio-
sensor has been reported whereby an immobilized PSA antibody on 
the	SiNW	surface	was	used	to	recognize	the	PSA.	This	ultrasensitive	
method (below 1 fg/ml) could be attained by adjusting the dimen-
sion	of	 the	 SiNW	and	 the	 doping	 concentration	of	 the	 Si	 channel	
(Zhang	&	Ning,	2012).	An	integrated	microfluidic	purification	device	
system	and	a	SiNW	FET	array	was	used	to	analyse	prostate	as	well	
as breast cancer markers (Stern et al., 2010). The purification device 
was used to pre-isolate the target molecules from whole blood by 
binding them to specific antibodies immobilized on the channel and 
subsequently cleaved by the photochemistry. The purified target 
molecules	were	then	transferred	to	the	NW	cell	for	real-time	sens-
ing. PSA at a concentration of 2.5 ng/ml and CA 15.3 (carbohydrate 
antigen-15.3) (30 U/ml) were detected from whole blood (Stern et al., 
2010).
Carbon	 NTs	 based	 nanosensor	 have	 also	 been	 used.	 CNTs	
show a unique combination of mechanical, electrical and electro-
chemical properties, that make them ideal components in diagnos-
tic	 biosensors.	 As	 biosensors,	 single-walled	 CNTs	 (SWCNTs)	 hold	
promises for detecting key biological analytes, including nitric oxide 
(NO),	 glucose,	H2O2 and others (Heller et al., 2009; Iverson et al., 
2015;	Kim	et	al.,	2009;	Ulissi	et	al.,	2014;	Zhang	et	al.,	2011).	DNA-
SWCNTs	conjugates	can	show	molecular	recognition	that	are	DNA	
and electrocatalytic capacity for dopamine oxidation (Li, Wang, 
et	al.,	2017).	Moreover,	the	application	of	NPs	as	labels	in	electro-
chemical measurements has also been reported with performance 
improvements, since the labels also act as signal amplifiers. PtCu 
bimetallic	NPs	loaded	on	2D/2D	reduced	graphene	oxide/graphitic	
carbon	nitride	(PtCu@rGO/g-C3	N4)	provided	large	surface	area	and	
biocompatibility, for immobilization of secondary antibodies. These 
NPs	acted	as	signal	amplifiers	 in	electrochemical	 impedance	spec-
troscopy measurements, since they present good activity for the 
reduction of hydrogen peroxide (H2O2), with a linear range of 50 fg/
ml	to	40	ng/ml,	and	LOD	of	16.6	fg/ml	(S/N	=	3)	for	prostate-spe-
cific antigen (PSA), which is often used for prostate cancer screening 
(Feng, Li, et al., 2017).
Liu et al. (2020) reported the development of a nanosensor for 
ratiometric luminescence detection of hydrogen sulphide (H2S) in 
aqueous solution and live cells using mesoporous silica nanoparticle. 
The change in the level of H2S in the body is associated with several 
diseases, such as Alzheimer's disease, Down's syndrome, diabetes, 
liver cirrhosis and even cancers (Lin et al., 2015). As an example, the 
H2S level is directly implicated with the inflammation of the cancer 
cells. But there is no simple and quick determination of this marker 
(Szabo, 2016). As shown in Figure 8, the sensors containing meso-
porous	silica	nanoparticle	 (MSN)	present	a	reference	signal	due	to	
conjugated fluorescein isothiocyanate (FITC) and an H2S responsive 
unit with embedded ruthenium(II) (Ru(II)) complex. The synthe-
sized	Ru@FITC-MSN	emit	luminescence	emission	bands	centred	at	
520 nm (FITC) and 600 nm (Ru(II) complex). The emission of Ru(II) 
complex when quenched upon addition of copper ion (Cu2þ), forms 
an	 in	 situ	RueCu@FITC-MSN	nanosensor.	When	 reacted	with	H2S 
in HEPES buffer solution, turn on the emission of Ru(II) complex 
showing the ratiometric luminescence response to H2S in solution 
(Liu et al., 2020).
Nanoparticles	have	also	been	highly	used	to	improve	the	perfor-
mance of optical biosensors either by serving as labels for signal am-
plification or as immobilization substrate. For instance, constructed 
silica-coated Ag SERS nanotags were used to detect matrix metal-
loproteinases 9 (MMP-9), whose early detection can be essential 
F I G U R E  7 Analytical	parameters	for	validation	of	biosensor	
performance
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sequence-dependent.	For	example,	(AT)15-wrapped	as	specific	NO	
sensors (Ulissi et al., 2014; Zhang et al., 2011) and (GT)15-wrapped 
SWCNTs	 as	 H2O2 sensors in the biological system (Heller et al., 
2009).	 SWCNTs	 show	 distinctive	 Raman	 and	 photoluminescence	
properties	 in	 the	nNIR	spectral	 region.	These	 features	make	them	
suitable for bio-imaging, due to minimal optical scattering and ab-
sorption	in	the	NIR	range	(700	–2,500	nm)	(Smith	et	al.,	2009).	It	has	
been demonstrated (Heller et al., 2009; Jin et al., 2010) that the sin-
gle-stranded	DNA	(GT)	15	wrapped	around	the	SWCNTs	surface	is	
a very effective approach to detect H2O2 presenting excellent spec-
ificity, and sensitivity to single-molecule, in addition to high spatial 
and temporal resolution from cells. The H2O2 is detected by fluores-
cence	quenching	of	SWCNTs	wrapped	with	(GT)15	(Jin	et	al.,	2010).	
Moreover,	SWCNT's	Raman	signals	have	also	been	applied	to	tissue	
labelling (Liu et al., 2008; Zhou et al., 2016). Yu et al. (2006) also 
an	electrochemiluminescence	(ECL)	immunosensor	based	MWCNTs	
(multiwalled	CNTs)	equipped	with	multiple	enzyme	labels	for	the	de-
tection of PSA in serum and tissue lysates. The detection of PSA in 
human serum samples was compared to the standard ELISA tech-
nique	and	showed	the	high	accuracy	of	immunosensors,	with	a	LOD	
(Limit of Detection) of 4 pg/ml in serum.
Kwon	et	al.	 (2010)	combined	conducting	polymer	 (polypyrrole)	
NTs	with	aptamers,	bonded	to	the	NTs,	to	develop	a	biosensor	for	
the detection of VEGF (Vascular endothelial growth factor). VEGF is 
a signalling protein that promotes the growth of new blood vessels, 
playing a fundamental role in angiogenesis, and therefore cancer 
development.	 Two	 carboxylated	 polypyrrole	 carbon	 NTs	 (CPNTs)	
of differing diameters were synthesized. The first ranged between 
190–220 nm and the second between 100–130 nm. Although both 
CPNTs	displayed	a	high	degree	of	sensitivity	in	detecting	VEGF,	the	
smaller diameter exhibited approximately two fold higher sensitivity, 
emphasizing	the	role	of	tube	size	(Kwon	et	al.,	2010).	This	is	similar	
to the effect of wire diameter on the sensitivity of FET devices (Li 
et al., 2005). The improved sensitivity of the smaller tube diameter 
transducer was attributed to better conductivity as a result of the 
enlarged surface area exposed. In addition, rapid real-time detection 
adds advantages to the system, since there is no need for labelling 
samples	(Chen	et	al.,	2011).	Kwon	et	al.	(2010)	were	able	to	detect	
unmatched levels of VEGF, which can have massive repercussions in 
the early detection of several cancers. Furthermore, the biosensor 
system developed is reusable, a very attractive property in diagnos-
tic platforms.
Prostate-specific membrane antigen (PSMA), a glycoprotein ex-
pressed in the prostatic epithelium endowed with enzymatic activ-
ity, is a promising diagnostic marker (Burger et al., 2002). Juzgado 
et al. (2017) reported on a ECL ELISA-like sensor based on carbon 
NTs	combined	with	a	specific	sandwich	immunoassay	for	the	PSMA	
detection.	The	use	of	CNTs	for	a	 immunoassay	ECL	sensor	for	the	
detection of 4 different prostate cancer biomarkers was presented 
(Kadimisetty	et	al.,	2015).	They	functionalized	the	CNT-based	sensor	
transductor surface and to immobilize the recognition unit (e.g. the 
antibody).
The fabrication of an ECL immunosensor, based on the use of 
functionalized	MWNTs	(f-MWCNTs,	Figure	10a),	for	the	detection	of	
PSMA in cell lysates has been reported (Juzgado et al., 2017). Amino 
groups	were	 introduced	onto	the	sidewalls	of	oxidized	CNTs	using	
a combination of amidation and diazonium radical coupling reac-
tions.	The	amino	groups	at	the	CNT	sidewalls	were	then	derivatized	
F I G U R E  8 Schematic	of	nanosensor	for	H2S detection (Liu et al., 2020). Figure reproduced with permission from Elsevier
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to covalently bind the anti-PMSA monoclonal antibody (Ab 7E11c) 
used, while the maleimidic groups were exploited to anchor the im-
munoconjugate onto the surface of the electrode.
In	order	to	highlight	the	specific	role	played	by	CNTs	in	the	im-
munosensor performance, a second type of surface was prepared 
where	 the	 electrode	modified	with	 the	 electrografted	 PNSA	 (po-
ly-(N-succinimide	 acrylate)	 film	 was	 directly	 incubated	 with	 the	
monoclonal	antibody	7E11c,	that	is,	without	the	intermediate	CNT	
(Figure 10b). For the preparation of the control immunosensor, the 
same	concentrations	of	7E11c	antibody	as	in	the	case	of	f-MWCNT@
mAb were used. In this instance, significantly lower ECL signals were 




Additionally,	 CNTs	 have	 also	 been	 used	 to	 improve	 the	 per-
formance of graphite rod electrode in glycerol detection. These 
nanostructures increased the effective surface area of the working 
electrode, for enzyme immobilization and electron transfer, and in 
conjugation with tetrathiafulvalene the designed biosensor demon-
strated	 a	 very	 high	 sensitivity	 (29.2	 ±	 0.9 µA/mM.cm2) towards 
glycerol	 (linked	to	diabetes	type	II).	The	device	displayed	 low	LOD	
(18 µM), a linear range from 0.05 to 1.0 mM, high selectivity and 
satisfactory stability (Ramonas et al., 2019). In another example, 
F I G U R E  9 Detection	of	MMP-9	protein	by	SERS	Immunoassay.	(a)	Schematic	of	SERS	immunoassay:	fabrication	of	SERS	tags	and	of	
MMP-9	PcAb-conjugated	magnetic	beads,	in	addition	to	the	resulting	sandwich	for	SERS	detection.	(b)	TEM	images	of	(i)	2	nm	AgNPs	and	
(ii)	15	nm	AgNPs	and	(iii)	40	nm	AgNPs	prepared	by	electrochemical	method.	(iv)	UV–Vis	absorption	spectrum	of	AgNPs	(Zhao	et	al.,	2019).	
Figure reproduced with permission from Elsevier
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SWCNTs	 were	 used	 to	 improve	 the	 performance	 of	 microbe	 de-
tection on a piezoelectric quartz crystal sensor, by acting as the 
electronic transducer and cross-linker for the immobilization of 
pleurocidin, an antimicrobial peptide. The sensor was able to detect 
microbes in 15 minutes. (Shi et al., 2017).
3.1.3  |  Nanosheets
Graphene is the most used two-dimensional (2D) nanomaterial, 
which play an important role in the biosensing devices (Feng et al., 
2012; Sadlowski et al., 2018; Wang et al., 2017) because of its ex-
ceptional physical, optical, electrochemical and magnetic properties 
(Klukova	et	al.,	2016;	Liu	et	al.,	2012;	Morales-Narváez	&	Merkoçi,	
2018). Various kinds of graphene materials have been used in bi-
osensors including pristine graphene, functionalized graphene 
such	 as	 graphene	 oxide	 (GO)	 (Yu	 et	 al.,	 2020),	 reduced	 graphene	
oxide	(rGO)	(Pei	&	Cheng,	2012)	and	graphene-based	QDs	(GQDs)	
(Moriyama et al., 2009). Graphene-based biosensors are organized 
in two main groups. The first, where functioned graphene materials 
including	GO	and	rGO	(Peña-Bahamonde	et	al.,	2018;	Suvarnaphaet	
& Pechprasarn, 2017) are assembled onto the biosensor surface 
[electrode, FETs channel, etc.] to create an interface for improved 
assembling of molecular receptors. The second, where graphene 
materials are used for the construction of novel nanocomposites 
(Krishnan	et	al.,	2019;	Mao	et	al.,	2010)	 to	be	used	as	electrodes.	
In this group, biosensor signal amplification and unique catalytic/
chemical activity are used for sensitive protein biomarker analysis 
(Li et al., 2011, 2016).
In graphene sheets, the strong cross-linking between carboxylic 
acid groups on graphene materials and the amine groups of antibod-
ies	(COOH-NH2) was used for immobilizing antibodies on novel bio-
sensor interfaces (Mao et al., 2010; Zhang et al., 2013). The inclusion 
of graphene materials increased the loading amount, orientation and 
antibody binding capacity. For example, a graphene-modified sensor 
platform with increased surface area was developed, with immo-
bilized	 antibodies	 assembled	 through	 COOH–NH2 in combination 
with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 
N-hydroxysuccinimide	(NHS),	that	achieved	a	low	detection	limit	of	
2 pg/ml (Li et al., 2011).
Graphene materials have been applied in FET biosensors, for the 
construction	of	2D	nano-FET	biosensors	(Ray	et	al.,	2018;	Xu	et	al.,	
2019), with several advantages such as higher amount of receptor 
biomolecules, low noise and high sensitivity, compared with 1D FET 
biosensors (Mukherjee et al., 2015). Graphene-based biosensors 
have	been	used	for	the	detection	of	microRNA-21	(Kilic	et	al.,	2015;	
Yin et al., 2012), and graphene-modified electrodes were used in ECL 
biosensor	 (Xu	 et	 al.,	 2011,	 2015)	 for	 PSA	detection.	Carbon	 elec-
trodes modified with a thionine–graphene composite were used to 
develop an electrochemical immunoassay sensor for the quantifica-
tion	of	Bax	protein	in	tumour	cells	(Xu	et	al.,	2013)	performance	and	
easy handling into varied structures (flexibility) (Yang et al., 2018).
3.1.4  |  Nanorods
Nanorods	have	also	been	used	for	improvement	of	biosensors	per-
formance, due to their unique properties and shape. Ahmad et al. 
(2017)	 reported	 grown	 vertically	 aligned	 ZnO	NR	 decorated	with	
CuO,	 on	 fluorine	 doped	 tin	 oxide	 (FTO)	 electrodes.	 This	 unique	
CuO-ZnO	NR	hybrid	 offers	 a	 large	 surface	 area	 and	 a	 penetrable	
substrate, thereby enabling improved electrochemical properties 
in glucose oxidation (Figure 11a). As a result, these fabricated elec-
trodes (Figure 11b) exhibit high sensitivity (2961.7 μA/mM.cm2), lin-
ear	range	up	to	8.45	mM,	 low	LOD	(0.40	μM), and short response 
time (<2 s) and applicability for glucose detection in human serum 
samples	 (Ahmad	 et	 al.,	 2017).	 In	 another	 study,	 ZnO	 NR	 powder	
surface-coated with carbon material was used as a working elec-
trode for non-enzymatic glucose detection with low detection limit 
of 1 mM and a linear range from 0.1 to 10 mM was attained. The thin 
amorphous carbon layer (1 nm) is fundamental for the improving of 
sensing electrons and promoting the oxidation-redox reaction, since 
is	the	carbon	decoration	that	makes	ZnO	react	directly	with	glucose	
in	the	non-enzymatic	detection.	Therefore,	is	inferred	that	ZnO	ac-
celerate the electron transfer, while carbon film offers binding sites 
and electron transportation platforms for glucose (Chung et al., 
2017).	 Taking	 into	 account	 the	NR’	 advantages	 in	 electrochemical	
F I G U R E  1 0 CNTs-based	immunosensor.	A	schematic	representation	of	the	f-MWCNT@mAb	immunosensor	(a)	and	the	control	antibody-
based immunosensor (b) developed in this work. Immunosensors are anchored to an optically transparent electrode covered by a polymer 
layer.	PSMA	antigen	is	specifically	recognized	by	the	capture	antibody	(7E11c,	mAb)	linked	to	the	NTs	or	directly	grafted	onto	the	polymer	
surface. The quantification is performed by using the detection antibody (D2B, mAb@Ru) (Juzgado et al., 2017). Figure reproduced with 
permission from Royal Society of Chemistry
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sensing, Zhao et al. (2016) developed a glucose biosensor based on 
ZnO	NR	on	a	chemically	reduced	graphene	film.	This	system	allows	
the electron transfer between glucose oxidase and the electrode 
due	to	the	placement	of	ZnO	NR	between	the	redox	centre	of	glu-
cose oxidase and the electrode. With this approach, a biosensor with 
a sensitivity of 17.64 μA/mM was achieved (Zhao et al., 2016).
3.1.5  |  Quantum	dots
Quantum dots are used in luminescence sensors, electrochemical, 
optical and photoelectrochemical (PEC) biosensors, such as ECL. 
Carbon and graphene QDs have been utilized in the fabrication of 
immunosensor. (Li, Jia, et al., 2017; Zhou et al., 2015). Desmin, an in-
termediate filaments protein type III, is one of the earliest expressed 
muscle-specific proteins. Its increased expression is also linked to 
colorectal	 cancer.	 Carbon	 QDs,	 quasi-spherical	 graphite	 NC	 with	
photoluminescence at about 455 nm, were used as an antibody sub-
strate for desmin. The linear relation (in the range of 0.7–4.3 ng/ml) 
between desmin concentration and photoluminescence of carbon 
QDs makes these particles a potential biosensor for desmin detec-
tion (Li, Yan, et al., 2017). In another study, polyarginine-graphene 
QDs were used to modify glassy carbon working electrode. The QDs 
addition was transduced in a remarkable increase in surface area and 
therefore active sites for polyarginine to provide signal amplifica-
tion. The detection of malondialdehyde, one of common biomarkers 
of oxidative stress, was achieved at a lower limit of quantification 
(0.329 nM). This was possible since polyarginine-graphene QDs ac-
celerate the rate of electron transfer of malondialdehyde and have 
a good electroactivity (Runsewe et al., 2019) for redox reaction of 
the biomarker, enhancing its detection sensitivity (Hasanzadeh et al., 
2017). Carbon QDs were embedded in a ZrHf metal–organic frame-
work	 (ZrHf-MOF)	which	shows	strong	 fluorescence	and	enhanced	
amino-functionalization.	Carbon	QDs-ZrHf-MOF	was	used	as	a	scaf-
fold for securing aptamer strands to detect human epidermal growth 
factor receptor-2 (HER2) and living HER2-overexpressed MCF-7 
cells, and, this way, provide an early cancer detection. The addition 
of amino-functionalized carbon dots can not only enhance the bind-
ing ability of aptamer strands but also boost the electrochemical ac-
tivity of electrode (Gu et al., 2019).
3.1.6  |  Nanocomposites
Some studies combine different nanomaterial to gather in the same 
biosensing device different properties that contribute for fur-
ther	enhancement	of	performance.	For	example,	ZnONRs-AuNPs	
nanohybrids have been produced and used for electrochemical 
detection of the ovarian cancer antigen CA-125/MUC126. Using 
cyclic voltammetry measurements, a detection of 2.5 ng/μl was 
obtained, which is a 100-fold lower than the detection limit using 
an	immunoblot	system	(Gasparotto	et	al.,	2017).	The	Au	NPs	onto	
ZnO	NR	surface	provides	a	favourable	platform	for	efficient	load-
ing of anti-CA-125 antibody via binding with cystamine and gluta-
raldehyde. Researchers (Gasparotto et al., 2017) have tested that 
biomolecules	immobilization	on	AuNPs	increases	the	their	stability	
and supports the maintenance of biomolecules activity. Besides, by 
using	AuNPs	 the	 direct	 electron	 transfer	 between	 redox	 species	
and bulk electrode materials is facilitated, due to their conductive 
nature,	which	and	improves	the	electrochemical	sensing.	ZnO	na-
nostructures are suitable to immobilize and modify proteins due to 
its biocompatibility and biomimicry, as well as large specific area, 
high chemical stability and high isoelectric point (IEP ~9.5). Their 
semiconductor properties also offer an excellent channel for effec-
tive carrier transport during the redox process. The higher value of 
sensitivity in this biosensor is a result of high adsorption, effective 
antibody loading and possible fast electron communication charac-
teristics	of	both	ZnO	nanostructures	and	AuNPs	(Gasparotto	et	al.,	
2017). Another example of nanocomposites used in biosensors is 
a glassy carbon electrode modified with 3D graphene and hybrid 
Au	 nanocages	 (AuNCs)/amino-functionalized	 multiwalled	 CNTs	
(MWCNTs-NH2). This composite device was used for label-free and 
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selective detection of MCF-7 breast cancer cells via differential 
pulse voltammetry. The fabricated device showed high specificity 
and	sensitivity	(in	the	range	of	1.0	×	102	to	1.0	×	106 cells/ml, with 
LOD	80	 cells/ml)	 for	MCF-7	 cells	 detection	 due	 to	DNA-labelled	
antibodies and nanomaterial-based signal amplification. This ap-
proach combines analyte capture capacity with signal amplification 
in sandwich-type biomimetic interface. The use of amine-function-
alized	MWCNTs	(MWCNTs-NH2) as a support is attractive because 
these	 modified	 CNTs	 have	 useful	 properties,	 such	 as	 high	 elec-
tronic conductivity, chemical stability, high dispersibility in water 
and the ability to facilitate electron transfer to amplify the current 
signal and improve the stability of the biosensor. Furthermore, hol-
low	AuNCs	deliver	larger	specific	surface	areas	and	more	exposed	
active sites, with simultaneous electrocatalytic activity (Yang, Fu, 
et al., 2018).
Other	studies	combined	nanomaterial	to	act	as	labels,	achieving	
superior levels of performance in electrochemical sensors. For exam-
ple, Li, Zhang, et al. (2017) reported amino-functionalized cobaltosic 
oxide @ ceric dioxide nanocubes with core-shell morphology com-
bined	with	sea-urchin	like	gold	@	platinum	NPs	(Co3O4@CeO2-Au@
Pt) conjugate with secondary antibodies to act as labels for signal 
amplification (Figure 12). These nanomaterials showed outstanding 
electrochemical properties and improved auxiliary catalytic activity 
of	Co3O4@CeO2-Au@Pt.	High	 electrocatalytic	 current	 responses	
led to the reduction of hydrogen peroxide (H2O2) and proved that 
this nanomaterial composite mimics enzymatic catalyses. In addition 
to	the	nanolabels,	electrodeposited	gold	NPs	(D-Au	NPs)	on	glassy	
carbon electrodes were used as antibodies carriers in sensing plat-
forms. This combination allowed a broad linear range of 100 fg ml−1 
to 80 ng ml−1 with a low detection limit of 33 fg ml−1 for detection 
of squamous cell carcinoma antigen, a tumour biomarker of several 
cancers (Figure 12).
Recently,	 a	 surface	 modified	 with	 Au/Ag–rGO,	 and	 aminated	
GQDs (graphene QDs) and carboxyl QDs were combined to form 
an	electrode.	 In	 this	 study,	Au	and	Ag	NPs	were	used	 for	 the	 ad-
sorption of PSA antibody, and meanwhile, GQDs served for ECL sig-
nal amplification (Farid et al., 2015; Wu et al., 2016). Additionally, 
CQDs-based composites have been reported for the detection of 
microRNA	 (Hu	et	al.,	2010;	Liu,	Ma,	et	al.,	2017).	GQDs	 in	combi-
nation	with	AuNPs	were	employed	to	develop	a	FRET	biosensor	for	
detecting a gene sequence (Shi et al., 2015). An impedimetric im-
munosensor consisting of a mercaptopropionic acid-modified gold 
electrode	functionalized	with	silica-coated	gold	NPs,	CdSe	QDs	and	
the anti-CA-125 monoclonal antibody was used for the detection of 
the CA-125 serum biomarker in patients with ovarian cancer (Johari-
Ahar et al., 2015).
QDs were also used to detect Leishmaniosis, a parasitic disease. 
The most common forms include cutaneous leishmaniasis. Surface 
antigens leishmania-specific were detected based on a method that 
combinationed magnetic beads and CdSe QDs with a specificity of 
100%	and	a	low	LOD	of	3,125	ng/μl	for	Leishmania	DNA	(Andreadou	
et al., 2016).
The combination of nanomaterial arrangements has been em-
ployed, not only in electrochemical biosensors, but also in optical 
and electroluminescent sensors. For example, a novel surface plas-
mon	resonance-based	ECL	sensor	with	DNA	tetrahedral	scaffolds	as	
platform	and	multiple	luminol	modified	AuNPs	as	enhancer	was	de-
veloped for the sensitive differentiation of cancer cells via telomer-
ase	activity	 (Feng,	Zhou,	et	al.,	2017).	Proximal	metallic	NPs	could	
quench the ECL emission of semiconductor QDs due to Förster en-
ergy transfer, but at a certain distance, the coupling of light emission 
with SPR result in enhanced ECL. Thus, the modification strategies 
and	distances	control	between	QDs	and	metallic	NPs	are	critical	for	
the ECL intensity of the QDs. The telomerase activity detection limit 
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was two orders of magnitude lower than commercial ELISA kits. The 
performance of the sensors was the result of tetrahedral scaffolds of 
DNA,	modified	with	three	thiol	groups,	anchored	on	the	surface	of	
cadmium sulphide QDs-GCE, building an uniform telomerase cover-
age	on	the	electrode	surface.	The	rigid	pyramidal	structure	of	DNA	
tetrahedron also caused the precise regulation of distance separa-
tion	between	AuNPs	and	QD.	 In	addition,	multiple	 luminol	AuNPs	
assembled	 on	 DNA	 tetrahedral	 scaffolds	 caused	 an	 greater	 SPR-
ECL signal which contributed to improvement sensors performance 
(Feng, Zhou, et al., 2017).
Other	authors	 (Heidari	 et	 al.,	 2019)	used	a	 similar	 strategy	 for	
detection of p53 protein, which can be used in early detection of 
cancer, monitoring both the cancer progress and clinical prognosis 
and achieving a dynamic range of 20 and 1000 fg/ml with a calcu-
lated	LOD	of	4	fg/ml.	In	this	approach,	cadmium	sulphide	NC	were	
immobilized on the glassy carbon electrode and anti-p53 antibody 
were	conjugated	to	AuNPs	and	 introduced	to	the	process	through	
formation of a sandwich-type immunocomplex. The ECL of cadmium 
sulphide	NC	evoked	the	surface	plasmon	resonance	of	AuNPs	which	
in	return	amplified	the	CdS	NCs	ECL	intensity	(Heidari	et	al.,	2019).	
Another approach for performance enhancement in ECL sensors re-
lied on PdCu nanocubes supported single-walled carbon nanohorns 
(PdCu@SWCNHs)	 immobilized	 with	 3,4,9,10-perylenetetracarbox-
ylic acid (PTCA) conjugated luminol, forming a novel self-catalysed 
luminescence emitter. This immunosensor exhibited a wide linear 
detection range of 0.1 to 25 ng/ml with a relatively low detection 
limit of 0.05 pg/ml, in clinical serum samples. This performance is 
a result of the introduction of PTCA into the luminol/H2O2 ECL 
system, responsible for the increment of the luminescence signal, 
stability	and	hydrophilicity	of	pristine	SWCNHs.	Moreover,	PdCu@
SWCNHs	 nanohybrid	 showed	 superior	 catalytic	 activity	 towards	
H2O2 that could further amplify the ECL signal of luminol/ H2O2 sys-
tem. Additionally, the good biocompatibility and high specific sur-
face area of PdCu nanocubes allowed successfully immobilization of 
detection antibody (Liu, Wang, et al., 2017).
Electrochemiluminescence/Electrogenerated chemilumines-
cence immunosensors based on modified transducers embedding 
metal	 and	 silica	 NPs,	 (Valenti	 et	 al.,	 2016)	 magnetic	 NPs	 (Gandhi	
et	al.,	2016)	and	NW	(Ma	et	al.,	2016),	were	shown	for	instance	to	




nanohybrid for the development of an optical sensor. The sensing 




High-throughput analysis systems are fundamental for current 
healthcare needs, since more information in shorter time is neces-
sary for an accurate diagnosis and early treatment. To address this 
challenge, biosensors with the ability of detect, simultaneously, mul-
tiple and different analytes, and with high sensitivity, in the same 
sample	had	been	developed	 (Kk	&	Chong,	2011).	This	capability	 is	
F I G U R E  1 3 (a)	Image	of	a	sensor	array	deposited	on	polyamide	substrate	and	it	comparison	with	a	cent;	(b)	combined	detection	of	
glucose and cortisol molecule with impedance measurements at 1 Hz and 100 Hz frequencies (collectively spiked glucose and cortisol 
concentrations as displayed on x-axis) (Munje et al., 2017); (c) SEM images observed for (i) unmodified SPCs (ii) graphene/SPCs and (iii) 
graphene/p-AHNSA/SPCs;	(d)	a	comparison	of	square	waves	voltammetry	observed	for	50	µM	DA	and	5-HT	at	unmodified	SPCs	(curve	a),	
graphene/SPCs	(curve	b)	and	graphene/p-AHNSA/SPCs	(curve	c)	at	pH	7.2	(Raj	et	al.,	2017).	Figures	adapted	with	permission	from	Elsevier
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extremely important in the diagnosis of diseases that required the 
screening of several biomarkers, whose marker levels can have a 
very low concentration. As these target molecules exist at the na-
noscale, biosensors with similar dimensions may allow a better in-
tegration between nanotechnology and biology, leading for faster 
diagnostics and more target therapeutics (Romeo et al., 2016; Wang 
et al., 2006). The ability to perform simultaneous multiple detection 
of biomarkers is desired and developed by all the diagnostic technol-
ogies	such	as	POC,	wearable	and	implantable.
Munje et al. (2017) developed a nanoporous flexible polyamide 
substrate with a region with zinc oxide thin films (Figure 13a), as the 
active region, for the detection of cortisol and glucose, since these 
two molecules have physiological interconnection and are directly 
correlated with type II diabetes. The use of the nanoporous poly-
amide substrate allows for nanoconfinement of biomolecules, which 
affect the electron transfer kinetics inside the nanopore. Thus, the 
mass transportation within the nanopores is impacted and the dif-
fusion time is reduced, leading to a high surface-to-volume ratio, 
enhancing	the	detection.	Nanoporous	surfaces	also	increase	selec-
tivity, through the size-based exclusion, which reduces the noise of 
complex environment and stability of biomolecules captured inside 
a nanopore. The results of electrochemical detection of cortisol and 
glucose in synthetic sweat are demonstrated in Figure 13b, at 1 and 
100 Hz.
Using a different approach, Raj et al. (2017)developed a biosensor 
for dopamine (DA) and serotonin (5-hydroxytryptamine) (5-HT. As 
previously mentioned, dysregulation of dopaminergic transmission 
has been associated with neurological disorders such as Parkinson's 
disease,	Schizophrenia	and	Tourette's	syndrome,	among	others.	On	
the other hand, serotonin is involved in several gastrointestinal dis-
orders like secretion, irritable bowel syndrome, food hypersensitiv-
ity and inflammatory bowel disease. It was demonstrated that the 
respective release of DA and 5-HT influence each other. For the DA 
and 5-HT simultaneous detection, graphene and a conducting poly-
mer	 of	 4-amino-3-hydroxy-1-naphthalenesulfonic	 acid	 (p-AHNSA)	
composite modified screen-printed carbon sensor (SPCs) was de-
veloped. The application of conducting polymer for modification 
of the surface of the electrode has been found to be as a superior 
strategy to increase electrical conductivity and chemical stability. 
The microscopic analysis (Figure 13c) of the graphene–polymer 
nanocomposite	film	showed	that	the	p-AHNSA	was	accumulated	on	
the SPCs surface with nanorod shaped particles, which interacted 
with graphene and formed a porous surface. This nanocomposite 
network is uniformly constructed through the entire surface and 
provides a larger electroactive surface area in comparison to the un-
modified sensor, promoting an easy and efficient electron transfer 
across the film.
For simultaneous determination of DA and 5-HTF, a mixture of 
both components in a pH 7.2 phosphate buffer was used and un-
modified	SPCs,	graphene/SPCs	and	graphene/p-AHNSA/SPCs	was	
electrochemically tested. As observed in Figure 13d, in unmodi-
fied SPCs, the oxidation peak current of DA and 5-HT are overlap-
ping,	making	accurate	detection	difficult.	 Instead	 for	p-AHNSA	or	
graphene-modified SPCs, two peaks for DA and 5-HT were detected. 
F I G U R E  14 (a)	Schematics	of	the	optical	beam	deflection	method	for	measuring	the	microcantilever	vibration	and	the	resonance	
frequency peaks (graph below) of a silicon cantilever. The dotted lines represent the signal before and the solid lines the signal after the 
immunoreaction	assay	for	the	control	(human	serum)	and	for	5×10−4 pg/ml of p24 in human serum; (b) Schematics of the multiple pathways 
for	light	scattering	by	the	gold	NPs	bound	to	the	microcantilever	and	optical	images	of	the	microcantilevers	after	the	immunoassays	(Kosaka	
et al., 2017) and (c) results of the biosensing of different concentrations of PSA in buffer (top) and in urine (bottom) (Suaifan & Zourob, 2017).
Images reproduced with permission from Public Library of Science and Elsevier
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The	LODs	and	dynamic	ranges	were	2	and	3	nM,	0.05–100	µM	and	
0.05–150	µM	for	DA	and	5-HT	in	graphene/p-AHNSA/SPCs	respec-
tively (Raj et al., 2017). Although some preliminary studies in human 
plasma samples were made, this biosensor needs more work until a 
simultaneous DA and 5-HT can be detected in human samples.
By functionalizing carbon dots with three different receptors, 
Zheng et al. (2019) showed that multiple bacteria can bind to them 
with different affinity. Using a mathematical statistical method ‘liner 
discriminant	analysis	(LDA)’,	they	were	able	to	discriminate	six	kinds	
of bacteria through their response pattern produced from the vari-
able fluorescence decrease of the carbon dots due to the binding 
ability differences of the bacteria.
Three	 independent	 SiNW	 biosensors	 with	 three	 different	
antibodies (PSA, carcinoembryonic antigen (CEA) and mucin-1) 
immobilized on them were developed (Stern et al., 2007). The con-
ductance-versus-time measurements offered simultaneous moni-
toring of PSA, CEA, and mucin-1, that were loaded sequentially to 
the	SiNW	FET	arrays.	The	multiplex	device	 revelled	 specific	 since	
the addition of serum containing PSA only resulted in a concentra-
tion-dependent	conductance	increase	for	NW1,	containing	immobi-
lized	antibody	for	PSA,	and	not	in	the	other	NWs	(Stern	et	al.,	2010).
Wang et al. (2020) demonstrated that in the presence of target 
miRNAs,	 duplex-specific	 nuclease	 (DSN)-assisted	 target	 recycling	
can be triggered, resulting in the release of QD and recycling of 
target	miRNAs.	MNs	 are	 linked	with	 dual-colour	QD	 through	 sin-
gle-stranded	DNAs	 (ssDNA)	that	are	complementary	with	miR296	
and	 miR-16,	 respectively.	 In	 the	 presence	 of	 target	 miRNAs,	 the	
forming	 miRNA/ssDNA	 hetero-duplexes	 will	 be	 simultaneously	
cleaved	by	DSN,	causing	the	release	of	target	miRNAs	and	QD	into	
the suspension. With the subsequent target recycling, simultaneous 
quantification of miR-296 and miR-16 can be realized by merely re-
cording fluorescence of QD in the suspension under single excitation 
light. The whole simultaneous detection can be realized by merely 
mixing the multifunctional nanocomposites with the samples. Then, 
the simultaneous quantification was realized by recording the cor-
responding amplified fluorescence signal of QD in the suspension. 
Femtomolar sensitivity and improved specificity was obtained with 
the	reported	method	in	the	simultaneous	detection	of	hsa-miRNA-
296-5p	and	hsa-miRNA-16-5p.
Multiplex detection of biomarkers is essential not only needed for 
precise diagnostics and further treatment, but also for high-through-
put diagnostic platforms. Therefore, quantifying simultaneously 
different biomarkers in several samples is a current challenge that 
nanomaterial-enhanced	sensors	are	trying	to	solve,	either	for	POC,	
wearable or implantable technologies.
3.2  |  Nanomaterial for point-of-care 
diagnostics devices
A better healthcare management can be achieved with quick diag-
nostics	 and	 appropriate	 data	 analysis,	making	 point-of-care	 (POC)	
devices imperative in the development of smart diagnostic systems 
for	personalized	health	care.	POC	devices	perform	fast	and	accurate	
diagnostics. These devices should be user-friendly, low-cost, sensi-
tive,	selective	and	robust.	Another	important	feature	of	POC	devices	
is the usage of mass production methods for device manufacturing 
(Barbosa & Reis, 2017). There are several methodologies to produce 
a	signal	 in	POC	devices,	and	they	often	depend	on	the	transducer	
used.	Thus,	optical	and	electrochemical	are	the	most	common	POC	
devices, examples of which are pregnancy tests and glucose metre, 
respectively.	POC	devices	were	integrated	with	nanomaterial	in	dif-
ferent sensing platforms, improving their performance and offer-
ing	 innovative	detection	systems.	Various	POC	devices	have	been	
developed in recent years, paving the way to next-generation of 
POC	testing	(Noah	&	Ndangili,	2019;	Quesada-González	&	Merkoçi,	
2018).
In order to achieve an early detection of HIV, it was developed 
a sandwich immunoassay based on nanomechanical and optome-
chanical	transduction	for	the	detection	of	p24	antigen	(Kosaka	et	al.,	
2017). The immunoreactions occurred in the surface of a single crys-
tal	 silicon	microcantilever	where	AuNPs	were	 used	 as	mechanical	
and	plasmonic	labels.	The	use	of	AuNPs	presented	some	advantages,	
like excellent electrical conductivity, ease of surface modification 
and	synthesis,	and	good	biocompatibility.	The	changes	in	the	AuNPs	
were detected by the microcantilever, which acts as a mechanical 
resonator,	weighing	the	mass	of	NPs	and	as	an	optical	cavity,	for	the	
plasmonic	signal	created	by	NPs.	With	this	approach,	signal	detec-
tion can be achieved mechanically or optically. In the first method, 
the microcantilever vibration is measured by the scanning optical 
laser	beam	deflection	technique.	In	the	second	method,	when	NPs	
are bounded to the microcantilever, the optical cavity modes and the 
localized surface plasmon modes couple each other at particular fre-
quencies, forming a hybrid plasmonic supermode, which enhances 
the	 scattering	of	 the	NPs	 (Figure	14a,	 b).	With	 this	work,	 authors	
(Kosaka	et	al.,	2017)	achieved	a	detection	limit	of	10−17	g/ml, which is 
two orders of magnitude below that detected by standard methods 
(nucleic acid amplification). Additionally, this technology claims the 
possibility	of	miniaturization	with	upscale	methods	 for	POC	appli-
cations. However, the detection of antigen p24 was performed in 
human	serum,	needing	to	be	validated	in	blood	(Kosaka	et	al.,	2017).
Suaifan	and	Zourob	(2017)	also	took	advantage	of	NPs	and	de-
veloped an electrochemical and optical biosensor for PSA detection. 
The biosensor analyte was created by covalently binding PSA-




tracted away from the gold sensing platform, changing its proper-
ties, as the impedance or the colour. These changes were measured 
by electrochemical impedimetric spectroscopy and by optical tech-
niques like surface plasmon resonance and colorimetric methods, 
as observed in Figure 14c. A gradual decrease in the charge trans-
fer resistance was observed with the application of different PSA 
concentrations. This reduction might be due to the variation of the 
self-assembled	 monolayer	 structure	 due	 to	 NPs-peptide	 moieties	
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dissociating from the sensing platform, upon PSA application. The 
elimination of the blocking and washing steps has made the screen-
printed	electrode	and	paper-based	low-cost	POC	biosensor	a	possi-
bility. However, more work is necessary to miniaturize and scale up 
production	methods,	for	use	as	a	commercial	POC	device	for	early	
diagnosis of prostate cancer.
New	technologies	based	on	microfluidic	paper-based	analytical	
devices,	incorporating	MWCNTs	were	recently	proposed	for	the	de-
tection of cancer markers (e.g., cancer antigen 125 (CA125) and car-
cinoembryonic	antigen	(CA))	(Wang	et	al.,	2012).	The	MWCNTs	were	
functionalized using carboxylic groups and coated with chitosan. 
This enabled their integration with emerging paper electronics and 
provides	low-cost,	and	disposable	portable	devices	for	POC	testing.	
A linear range for CA125 (0.001–75 U/ml), and for CA (0.05–50 ng/
ml) detection, which are much lower than the normal levels in real 
serum samples of the two cancer markers of 1.7–32 U/ml, and 
0–10 ng/ml, were reported (Wang et al., 2012). Chikkaveeraiah et al. 
(2009)	 reported	a	SWCNT-based	 sensor	 to	measure	 four	prostate	
cancer biomarkers in cancer patient serum simultaneously using an 
ECL immunoarray. The device provides adequate sensitivities within 
the normal clinically relevant levels for each biomarker, in addition 
to their real-time measurement. This device has the potential for 
F I G U R E  1 5 (a)	Diagram	showing	the	fabrication	of	the	flexible,	skin-attachable,	electrochemical	sweat	sensor	for	glucose	and	pH	
detection; (b) (i) Photographic image of the electrochemical sensor attached to the skin wet with sweat, (ii) Correlation of glucose 
concentration (left) and pH (right) measured by the developed biosensors (x-axis) with those available commercially (y-axis) in human 
sweat, (iii) performance of the biosensor attached to the skin in human sweat under mechanical deformation and (iv) change of glucose 
concentration and pH measured by the developed sensor attached onto skin along with different activities of meal injection and running for 
10	h;	(Oh	et	al.,	2018)	(c)	Schematic	of	the	stretchable	sensor	design,	the	enzymatic	immobilization	process,	the	catalytic	ink	and	screen-
printing	process	(Abellán-Llobregat	et	al.,	2017);	(d)	Time-dependent	current	responses	during	(i)	repeated	bending−releasing	cycles	of	the	
wrist, (ii) swallowing motions, (iii) repeated coughing actions, (iv) speaking of different words, (v) monitoring radial artery and (vi) carotid 
artery pulses (Ghosh & Mandal, 2017). Figures reproduced with permission from ACS publications and Elsevier
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application	 as	 POC	 diagnostic	 assays.	 Recently,	Wan	 et	 al.	 (2011)	
developed an ECL immunosensor for the simultaneous detection of 
PSA and interleukin-8 (IL-8) with a screen-printed carbon electrode 
based	 on	MWCNTs	 as	 detection	 platform.	 They	 reported	 a	 LOD	
(LOD)	of	5	pg/ml	for	PSA	and	8	pg/ml	for	IL-8,	suggesting	also	a	mul-
tiplexing capability, making this immunosensor a promising approach 
for	POC	testing	in	clinical	diagnostics.
3.3  |  Nanomaterial for wearable 
diagnostics devices
Advanced wearable electronic devices, which can be worn or at-
tached onto skin, had gain an increased interest in healthcare man-
agement, fitness and biomedicine, and it is expected to be expanded 
even further in the years ahead (Jayathilaka et al., 2019). Significant 
advances in wearable biosensors able to monitor the patient's physi-
ological state have been reported (Rodrigues et al., 2020). Since the 
tendency is to move towards integrated wearables, the conversion 
of actual devices into integrated devices involves a significant size 
reduction, while retaining their functional capabilities. Thus, nano-
material play a huge role in the development of new wearable bio-
sensors (Jayathilaka et al., 2019; Yang et al., 2017).
One	of	 the	biggest	challenges	 in	 the	development	of	wearable	
biosensors is reliability and un-interrupted monitoring of signals. 
Human epidermis is constantly exposed to bending and stretching 
movements during common physical activity. The excessive noise 
caused by the skin barrier, in addition to skin irritation and discom-
fort has an adverse effect on these devices. Taking this into account, 
a stretchable and skin-attachable electrochemical sensor for de-
tecting	 glucose	 and	pH	 in	 sweat	was	developed	 (Oh	et	 al.,	 2018).	
Stretchable electrodes were fabricated by layer-by-layer deposi-
tion	of	CNTs	on	top	of	patterned	Au	nanosheets	 (AuNS)	prepared	
by filtration onto stretchable substrate (Figure 15a). The use of 
nanosheets	and	NTs	allows	the	detection	of	small	changes,	increas-
ing the sensitivity of the final biosensor.
Graphene-based flexible composites with different materials 
and structures have resulted in excellent pressure sensors (Lv et al., 
2017). Graphene has also been used as a component of nanosheets-
based stretchable sensors for human motion detecting and monitor-
ing. Human motions and physical activities at different sites of the 
human body generate a wide range of crucial signals such as move-
ment disorders, respiratory disorders and blood pressure (Trung 
et al., 2016), which could be captured by highly sensitive pressure, 
tactile or strain sensors for continuous monitoring. Graphene and its 
derivatives have found usage in pressure sensors because of their 
significant piezoresistive (or piezocapacitive) properties.
Hydrothermally	 synthesized	 cobalt	 tungstate	 (CoWO4)/CNTs	
nanocomposite, with high conductivity and large surface area, were 
used	 as	working	 electrode	 on	 top	 of	 CNTs/AuNs,	 for	 glucose	 de-
tection,	 without	 use	 of	 any	 enzyme	 (Oh	 et	 al.,	 2018).	 Polyaniline	
(PANI)/CNTs,	 prepared	 via	 electropolymerization,	 were	 used	 for	
pH detection. Additionally, silver nanowire was deposited on the 
AuNS	 electrode	 to	 produce	 the	 solid-state	 stretchable	 reference	
electrode. The developed electrochemical sensor was encapsulated 
in a sticky polymer (silbione) and was conformably attached onto 
skin. The monitoring results show highly selective sensitivity, with 
readings of 10.89 μA/ mM.cm2 to glucose and 71.44 mV/pH with pH 
in sweat. The results were consistent even under repetitive defor-
mations of stretching by 30%. During glucose and pH sensing, there 
was no observed interference from other chemical components and 
ions existing in the human sweat (Figure 15b). Long-term stability of 
the sensor was performed, without any notable deterioration of the 
sensitivity of either glucose or pH. This study was only conducted 
for 10 days. Continuous monitoring of the change in glucose con-
centration and pH due to meal ingestion and running could be tested 
with this biosensor, since values could be stably detected in sweat 
after exercising, and regardless of the skin movements, surpassing 
the	major	drawbacks	of	actual	wearable	biosensors	(Oh	et	al.,	2018).
Abellán-Llobregat et al. (2017) developed two distinct stick-on 
platinum	nanoparticle	(PtNPs)-based	stretchable	electrochemical	bi-
osensors with the objective of measure glucose in the sweat. These 
authors used Pt-decorated graphite as the ink filler (Figure 15c). 
Additionally,	 PtNPs	 have	 high	 electroactivity,	 even	 with	 if	 the	
amount of Pt on the electrode is low, thus reducing the cost of the 
biosensor.	One	 of	 the	 developed	 devices	was	 enzyme-free,	 while	
the	other	 took	 advantage	of	 the	PtNPs	 system	 to	detect	H2O2 at 
less positive potentials; thus, minimizing, the interference of elec-
troactive species, such as ascorbic acid or uric acid, which are elec-
troactive at more positive potentials and can interfere in glucose 
detection. Both biosensors were tested with glucose in phosphate 
buffer. The enzyme-free biosensor detection was carried out by re-
cording the glucose oxidation current by chronoamperometry. The 
results obtained shown a sensitivity of 0.69 ± 0.06 µA/ mM.cm2 and 
a	LOD	of	6.6	mM.
The enzymatic detection using biosensor was performed after 
immobilization	of	glucose	oxidase	 (GOx)	on	a	Pt-decorated	graph-
ite electrode. Glucose quantification was detected by measuring 
the current as a result H2O2 reduction also by chronoamperometry. 
This greatly improved the sensitivity levels obtained with the en-
zyme-free sensor. Stretchability was also tested to understand the 
influence of stress-strain on glucose detection. Results shown that 
the	GOx/Pt-graphite	biosensor	can	be	stretched	up	to	75	±	1.3%	of	
its original size. Although authors claim a significant correlation be-
tween	GOx/Pt-graphite-based	biosensor	in	human	perspiration	and	
human blood with a commercial glucose metre, the measurements 
were taken in a glass container and not in the skin. Thus, this biosen-
sor needs to be studied in human skin before it can be elected as a 
wearable biosensor.
The development of wearable biosensors to be used directly 
onto the epidermis requires substrates with properties similar to 
the human skin, like biocompatibility and air permeability, among 
others. Despite the efforts to produce flexible wearable sensors, 
most of the reported sensors still present limited air permeability, 
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reducing the potential for continuous physiological detection, due to 
inflammation	of	skin	(Khan	et	al.,	2019).	Thus,	Yang,	Li,	et	al.	(2018)	
developed a breathable pressure sensor based on poly(vinylidene 
fluoride)	nanofibre	membranes	and	silver	NW.	The	porous	structure	
of the nanofibre membrane allows the air permeability and excellent 
breathability	(Gurley	value	=17.3	s/100	ml,	that	is,	there	are	neces-
sary 17.3 seconds for 100 ml of air to pass through a specified area 
of a separator under a specified pressure), making this a potential 
sensor for continuous monitorization of human physiological signals, 
such as respiration and heart rate (HR). For that, the sensor could 
be attached, for instance, in a face mask. Additionally, the sensor's 
biocompatibility was assessed through its attachment, for 24 h, to 
the forearm, showing no allergic reaction.
Another challenge in wearable biosensors development is their 
power supply. The commonly used separated power source has 
some inherent disadvantages, like joule heating effect. Thus, the de-
velopment of self-powered wearable biosensors is necessary.
In order to surpass this limitation, Ghosh et al. (2017) developed 
a self-powered wearable bio-inspired piezoelectric biosensor, ca-
pable of monitoring real-time human physiological signals such as 
arterial pulses, vocal cord vibration and gentle wrist movements. 
For this fish skins waste were used as it is composed of collagen 
nanofibrils, which is a biocompatible and biodegradable piezoelec-
tric polymer. The piezoelectricity properties are due to the presence 
of hydrogen bonding within the polypeptide chains. Due to the rich 
hydrogen bonding network of the stable crystalline structure of the 
collagen nanofibrils, they present superior dielectric property com-
pared to other available biopolymers. The dielectric properties are 
mainly influenced by trapping of free charges between fibres and 
air pores, known as Maxwell–Wagner–Sillars interfacial polarization 
effect (Samet et al., 2015). Taking this into account, authors devel-
oped a fish skin-based nanogenerator able to behave as an ultrasen-
sitive, highly durable pressure sensor, which successfully monitors 
real-time human physiological signals, as observed in Figure 15d. 
Furthermore, the fish skin-based nanogenerator produces sufficient 
output power to operate consumer electronics under human per-
ception (Ghosh & Mandal, 2017). The electricity generation capabil-
ity of this wearable biosensor, harvesting the bio-mechanical energy 
with longer endurance makes it valuable for a range of applications 
in continuous healthcare monitoring.
3.4  |  Nanomaterial for implantable 
diagnostic devices
Implantable biosensors can be an extraordinary tool to achieve early 
diagnostics and to continuously monitoring a disease. The under-
standing of the physiology and the pathological processes in organ-
isms, especially in humans, can be aided by in vivo sensors. However, 
implantable biosensors are far away from mass commercialization, 
F I G U R E  1 6 Schematic	showing	urine	testing	in	a	mouse	flank	tumour	model:	(a)	intravenous	injection;	(b)	renal	clearance	and	(c)	urine	
collection	(Kirkpatrick	et	al.,	2020).	Figure	adapted	with	permission	from	AAAS
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since they still present some challenges that need to be addressed. 
The biggest challenge corresponds to the foreign body response, 
but characteristics like porosity, surface chemistry, size, roughness 
or degradation time are also major limitations.
Implantable nanomaterial-enhanced sensors are emerging as a 
possibility to overcome these limitations, taking advantage of their 
size and unique properties (Rebelo et al., 2019; Shafiee et al., 2019). 
For example, in spite of the tumour detection tools available, clin-
ical detection of tumours remains a challenge. Currently, tumour 
sizes of 1 cm diameter are detected using imaging techniques or 
by analysing the blood markers shed by the tumour and can take 
up	 to	 10	 years	 to	 reach	 this	 size	 (Kwon	 et	 al.,	 2017).	 An	 activi-
ty-based nanosensor using the protease activity in a tumour was 
able	to	shed	peptide	fragments	concentrated	in	urine.	(Kwong	et	al.,	
2013; Warren et al., 2014). These peptides (tumour-penetrating li-
gands that engage active tumour trafficking pathways initiated by 
receptor	 binding)	were	 conjugated	 to	 iron	 oxide	NPs.	 These	NPs	
were injected into mice whose urine was collected. The size of tu-
mour in the urine was measured. The process is schematically illus-
trated below (Figure 16). The results indicate that the difference in 
tumour volumes between detection via application of HE4 blood 
serum	ELISA	(blood	biomarker)	and	tumour-penetrating	ABNs	was	
2.4-fold,	 that	 is,	 smaller	 size	 tumour	 can	 be	 detected	 by	 ABN’s	
(Loynachan et al., 2019).
In	 vivo	 sensing	 explored	 gold	 nanoclusters	 (AuNCLs)	 intrinsic	
catalytic activity in a multifunctional protease nanosensor. This de-
vice, which responded to disease microenvironments, was designed 




mice (Loynachan et al., 2019). The complex was specifically dis-as-
sembled by proteases at the site of disease. These proteolytically lib-
erated	AuNCLs	circulated	via	the	bloodstream	and	were	efficiently	
filtered into the urine through the kidneys due to their small size 
(<5	nm).	Urine	was	tested	with	AuNCLs	using	a	colorimetric	assay	for	
indication	of	disease	state.	The	NPs	showed	stability	in	physiological	
environments as they retained their catalytic activity. These com-
plexes avoided non-specific protein adsorption. These complexes 
were used in vivo detection in a colorectal cancer mouse model and 
successfully	 detected	AuNCLs	 in	 urine	 from	 tumour-bearing	mice	
with a facile colorimetric readout.
Carbon nanotubes are widely used in electrochemical biosen-
sors due to their unique electrical properties, allied with their high 
sensitivity, fast response, easy operation and favourable portability 
(Sireesha et al., 2018). Zhang et al. (2017) engineered tunable de-
fects	and	oxygen-containing	species	in	CNTs,	developing	an	aligned	
carbon	nanotube	fibre	(CNF)	as	an	electrochemical	biosensor	for	the	
ratiometric detection of ascorbic acid levels in live rat brains with 
Alzheimer's disease. At a low potential, the fibre surface facilitates 
the ascorbic acid oxidation, leading to higher sensitivity and selectiv-
ity and avoiding interference from other species that exists in brain. 
In order to evaluate the in vivo performance of these biosensors, 
they were implanted in a rat brain with and without Alzheimer's 
disease. The electrochemical results obtained by the implantable 
biosensors can be observed in Figure 17a. Two separate oxidation 
F I G U R E  17 (a)	(i)	Diagram	showing	the	in	vivo	setup	for	determining	ascorbic	acid	in	rat	brain;	(ii)	optical	images	before	and	after	the	
stereotaxic implant into the brain; differential pulse voltammetry recorded at (iii) the normal rat (blue) and rat brain models of Alzheimer's 
diseases (red) and at (iv) the rat brain model of Alzheimer's diseases before (red) and after (blue) injection of ascorbate oxidase (Zhang 
et	al.,	2017);	(b)	Schematic	of	CNTs-based	biosensor	synthesis;	(c)	(i)	representative	bioluminescence	images	denoting	tumour	burden	in	
the peritoneal cavity of nude mice inoculated with luciferase-expressing cell lines; (ii) method diagram of HE4 measurement in live tumour-
bearing mice; (d) (i) Variation in sensor emission centre wavelength after implantation into mice with four different orthotopic intraperitoneal 
tumour models, where the lighter lines represent traces from the emission within each mouse. (ii)Sensor response from all mice at 60 min 
after implantation. Cells of four different luciferase-expressing cell lines were used (Williams et al., 2018).Figures reproduced with 
permission from ACS publications and AAAs























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(used as control), suggesting that ascorbic acid was present in the rat 
brain. Despite authors claim high selectivity and accuracy, long-term 
stability of the implantable biosensors needs to be studied further in 
order to increase the potential of this application.
Although	CNTs	are	used	in	electrochemical	biosensors,	they	also	
possess characteristics that make them great choices for optical bio-
sensors,	like	photoluminescence	in	NIR	and	strong	resonance	Raman	
scattering	(Zhu,	2017).	The	NIR	photoluminescence	depends	on	the	
bandgap energy, which affects the local dielectric environment of 
the	CNTs.	The	DNA	wrapped	around	the	CNTs	modulates	this	local	
environment when a target analyte binds. The transition from a B to 
Z	confirmation	(DNA	polymorphism)—because	of	the	presence	of	di-
valent	metal	cations—causes	a	red	shift	in	the	bandgap	fluorescence	
(Barone et al., 2005; Heller et al., 2006). This transition is prevalent 
in	blood,	living	mammalian	cells,	and	tissues.	An	optical	CNTs-based	
biosensor for early detection of ovarian cancer, through the sensing 
of HE4 biomarker, was developed (Williams et al., 2018). This optical 
biosensor	was	developed	through	derivatizing	of	NIR-emitting	CNTs	
to transduce the binding of HE4 to an immobilized antibody. This an-
tibody-CNTs	complex	responded	specifically	to	HE4	by	modulation	of	
the nanotube emission wavelength (Figure 17b). For in vivo validation, 
the biosensor was implanted into mice and its emissions were mea-
suring an optical probe system for 24 hours (Figure 17c). From those 
results (Figure 17d), it is possible to observe a shift in biosensor emis-
sion wavelength, which correspond to the detection of HE4 in cancer-
ous mice with high express of HE4, when compared to control (with 
low expression of HE4). While this study promises great potential for 
early ovarian cancer detection, same limitations need to be overcome 
before it can pass to the next clinical translation phase. For example, 
biocompatibility needs to be evaluated and the long-term functional-
ization and stability requires further investigation (since authors only 
claim consistent emission in vivo for 38 days). In addition, biosensors 
performance, like sensitivity and detection limit, should be studied to 
verify its accuracy for this application.
Graphene is another well-known material used in electrochemical 
sensors. The effect of graphene in in vivo applications depends on 
how the graphene was synthesized and purified (Pinto et al., 2013). 
Implantable sensor using pristine graphene has found applications as 
a glucose detection system, (Gu et al., 2012; Lee et al., 2018; Pu et al., 
2018) neural stimulator and signal recorder, (Blaschke et al., 2017; 
Kostarelos	et	al.,	2017),	cardiac	monitoring	(Chen	et	al.,	2013)	and	bi-
ological	molecule	sensor	(Chen	et	al.,	2011,	2012;	Kasry	et	al.,	2011).	
High conductivity, electrochemical stability, flexibility and transpar-
ency make graphene an ideal candidate for neural interface design.
The optical transparency of graphene is useful in the study of 
neural	implants	(Kuzum	et	al.,	2014;	Park	et	al.,	2018).	Graphene	mi-
croelectrode arrays and graphene field-effect transistors have been 
used for neural stimulation (Thunemann et al., 2018). Wet-spun re-
duced graphene oxide have been used for free-standing penetrating 
electrodes (Apollo et al., 2015).
Blaschke et al. (2017) employed flexible arrays of graphene solu-
tion-gated FET to record brain activity in vivo which had a higher 
signal-to-noise ratio than traditional Pt electrode of similar dimen-
sions.	Nano-enhanced	sensors	offer	great	potential	to	redefine	the	
study and diagnostic of diseases, through their ability to sense a bi-
ological or chemical parameter in real time. However, the challenges 
involved in the designing of implantable nano-enhanced sensors are 
numerous and this potential will only become a clinical reality when 
these sensors completely fulfil all necessary requirements for in vivo 
applications.
4  |  CURRENT LIMITATIONS OF 
NANOMATERIAL IN DIAGNOSTIC 
BIOSENSORS APPLIC ATIONS AND FUTURE 
PERSPEC TIVES
Nanomaterial	has	successfully	addressed	diagnostic	biosensors	chal-
lenges using different approaches as presented in Section 3. However, 
these approaches have not led to a viable product nor achieved clinical 
validation. Therefore, current limitations of nanomaterial approaches 
in diagnostics biosensors and future perspectives for nanomaterial in 
medical diagnostic biosensors are discussed below.
Some nanomaterial-enhanced sensors have passed clinical valida-
tion and are currently commercialized, in particular glucose sensors 
such as i-STAT and Glucocard, and some are already in clinical trial 
phases (Table 3). However, most of the developed nanotechnology 
approaches reported in literature does not reach the final stage of 
development (Mahato et al., 2018). There are several reasons for this. 
The most important issue that limits the development and applica-
tion of nano-enhanced sensors in real life is related to the safety and 
toxicity of nanomaterial, their composition and particular properties. 
Second, most developed technologies focus only on analytical sen-
sitivity and detection limit as performance parameters, and neglect 
parameters such as accuracy, precision and stability. This is the reason 
why most reported biosensors do not use biological samples in their 
proof of concept. There is also lack of attention regarding the time of 
response, and time of operation of newly reported biosensing tech-
niques, which despite being crucial parameters of any biosensor ap-
plied in any real situation, are rarely reported. Third, biosensors need 
to be integrated into a fluidic and automated device, the so-called lab-
on-chip	(LOC)	devices,	with	integrated	detection	modes	in	order	to	be	
successfully commercialized. This is extremely complex and demands 
a multidisciplinary team with access to a diverse set of equipment's 
to do it. And finally, the nanomaterial production techniques are not 
always scalable, which hinders the product commercialization.
4.1  |  Safety and toxicity of nanomaterial
The safety and toxicity of nanomaterial can compromise the future 
development of nanomaterial-enhanced sensors, due to added cost 
of the manufacturing process due to security measures; damages to 
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the environment and public health when discharged in the case of 
point-of-care technologies; and the potential harm to patient health 
in the case of wearable or implantable technologies. These aspects 
are limiting the potential for commercialization and should be taken 
into consideration for future biosensors development. The possible 
toxic effects of nanomaterial are dependent on base material, shape, 
size, coatings, etc. However, to understand the toxicity associated 
with nanomaterial it is necessary to conduct control experiments 
and carefully analyse the data. Different studies of the same nano-
material, with different cell lines, amounts, shapes, among other pa-
rameters, could achieve different results of toxicity, being extremely 
difficult determine whether the cytotoxicity observed is physiologi-
cally relevant.
Metallic-based nanomaterial is the most widely used nanomate-
rial.	For	instance,	gold	NPs	are	known	for	the	outstanding	biocom-
patibility. However, the cell type used in toxicity assays can lead to 
different results. It was concluded that 33 nm citrate-capped gold 
nanospheres are not toxic to aby hamster kidney and human hepa-
tocellular liver carcinoma cells (Patra et al. 2017), but can be toxic to 
human carcinoma lung cell line (Alkilany & Murphy, 2010; Fratoddi 
et al., 2015; Patra et al., 2007).
The	 same	 can	 be	 observed	 in	 the	 case	 for	 silver	 NPs	 toxicity	
can be achieved by: (a) the release of Ag+ions, (b) the interaction of 
cells	with	silver	NPs	and	(c)	the	formation	of	reactive	oxygen	species	
(ROS).	Due	to	 its	small	particle	size	and	enormous	specific	surface	
area, the ions dissolution of nanosilver is much more rapid than in 
bulk	material.	 Additionally,	NPs	 have	 the	 ability	 to	 generate	 ROS,	
and to interact with, leading to a high toxicity for cells (Rebelo et al., 
2016; Reidy et al., 2013).




creases, significantly, when carbonyl, carboxyl and/ or hydroxyl groups 
are present on their surface (Magrez et al., 2006; Yuan et al., 2019).
With regard to QDs and its individual and unique physicochemi-
cal properties, there are discrepancies in the current literature about 
their toxicity. This happens because not all the QDs synthesized 
are alike. QD toxicity effect depends on their chemical composi-
tion, since they can contain compounds such as Cd and Hg. QDs 
toxicity depends on several parameters, resultant from individual 
physicochemical characteristics and environmental conditions, like 
concentration, size, charge, coating, and oxidative, photolytic and 
mechanical stability (Bottrill & Green, 2011; Filali et al., 2020). Thus, 
while	some	studies	show	their	toxicity	(Hoshino	et	al.,	2004;	Lovrić	
et al., 2005), in other's that evidence is not demonstrated (Ballou 
et al., 2004; Voura et al., 2004) and there are studies where the QDs 
toxicity depends on the dosage used (Li et al., 2020). Toxicity can 
be minimized by functionalizing the QD surface with biocompatible 
molecules. Methods for QD surface modification are presented else-
where	(Medintz	et	al.,	2005;	Smith	et	al.,	2008;	Xing	&	Rao,	2008).
In conclusion, it is not possible to affirm the toxicity of a nano-
material, per se, since it depends on a plethora of factors and the 
comparison between different literature studies should be carefully 
made, since, most of the times, the conditions are not the same. This 
means that nano-enhanced sensors development needs to take in 
consideration toxicity effects, especially when a wearable or im-
plantable sensors in envisioned.
4.2  |  Primary developmental focus on 
sensitivity and detection limit
Researchers aim to demonstrate engineering excellence of their 
nanosensing technologies in terms of increased endpoint detection 
sensitivities and lower detection limits. However, they tend to ig-
nore other analytical performance parameters mentioned above in 
this review, as well as batch-to-batch variability for a given material 
and fabrication method. The end result is that proof of concepts are 
published and the work moves towards a next hypothesis to prove. 
This has led to the lack of data proving reproducibility and chip-to-
chip variability for a given material and fabrication method. Indeed, 
without this benchmark, many devices will be unsuccessful in the 
commercial arena, despite incorporating high levels of academic in-
novation, particularly in the application of critical result endpoints 
such	as	in	medical	diagnostics.	Other	important	aspect	is	the	exces-
sive focus on sensitivity and detection limit itself. The most com-
mon performance metric use to estimate sensor sensitivity is the 
change in signal normalized by the original value of the signal (Cui 
et al., 2001). A more apt definition would be using the change in sig-
nal per unit change in analyte concentration which can be visualized 
through the calibration curve. Perhaps the most important metrics 
of sensor performance is the size of the device itself. Decreasing 
the sensing elements dimensions impacts the two most important 
performance	metrics	 of	 biosensors:	 LOD	 and	 response	 time.	 The	
LOD	of	biosensors	and	 its	correlation	with	sensor	dimensions	sig-
nal transduction efficiency and reaction-transport kinetics affects 
sensor performance. Signal transduction efficiency is related to the 
minimum number of analytes that must be captured at the sensor 
surface for obtaining an acceptable signal-to-noise ratio, while the 
reaction-transport kinetics are related to the time required for that 
capture to occur (Soleymani & Li, 2017). The response time of a sen-
sor is dictated by (a) the mass transport of the analyte to the surface 
of the sensor where the binding reaction can happen (Sheehan & 
Whitman, 2005; Squires et al., 2008) and (b) the affinity of that par-
ticular receptor–analyte system which becomes a limitation for the 
detection of trace amounts. Therefore, in many cases the signal-to-
noise ratio is improved in miniaturization; however, the target ana-
lytes capture on sensor surfaces takes longer due to the increase in 
mass	transport	times	(Kaisti,	2017).
Most sensors are essentially exposed-channel transistors that 
suffer from the drawbacks associated with other electronic devices, 
like electronic noise. A better understanding of the noise sources 
and will be needed for improved sensitivity and detection limit 
(Rajan et al., 2013). Also, ionic environment in which most sensing 
experiments are usually carried out and which does not allow for 
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ultrasensitive detection in physiological fluids. The ions in the elec-
trolyte solutions accumulate and form a layer around the analyte 







, where A is the ionic strength, is de-
sirable to ensure less charges are screened. This inhibits the ultra-
sensitive detection in physiological fluids. which is dependent on the 
binding affinity given by the equilibrium dissociation constant (KD). 
KD determines the occupancy of the receptor sites at a certain bulk 
analyte concentration.
Several design changes have been proposed to reduce the re-
sponse time of these biosensors into acceptable ranges to capture 
the enhanced signal-to-noise ratio of biosensors with critical di-
mensions. These changes include employing external forces such 
as pressure-drive flow (Yanik et al., 2010), electric field (Freedman 
et al., 2016) and thermal gradients (Wang & Cheng, 2016), or internal 
forces delivered through self-propelled nano/micromotors (Gu et al., 
2012). Diffusion-limited transport can be mitigated by di-electro-
phoretic manipulation of biomolecules (Lee et al., 2010; Yasukawa 
et al., 2007) and AC electroosmotic flow (Gong, 2010; Hart et al., 
2010) to drive the motion of molecules to the sensor surface.
In addition, the dimensionality of sensors affects their sensi-
tivity. Based on electrostatics considerations, it is well known that 
two-dimensional	 cylindrical	 NW	 are	 more	 sensitive	 to	 adsorbed	
charges compared to one-dimensional planar ion-sensitive field-ef-
fect transistor (ISFET) or chemical field-effect transistor (CHEMFET) 
(Nair	&	Alam,	2006).	These	authors	showed	the	detection	limit	of	a	
typical 2D nanowire sensor for the same response time is three to 
four orders of magnitude higher compared to planar 1D sensor,
Researchers have applied novel technologies in the development 
of biosensors. As the devices have gotten smaller enhancing the sig-
nal-to-noise ratio, little consideration has been placed to the effect 
of optimizing the mass transport to the sensor and the chemical re-
action that govern the binding kinetics. These affects the ultimate 
performance of the device. This results in the development of bio-
sensors that do not meet healthcare current needs and therefore are 
not use in the diagnostic market. This is because not all diagnostic 
tests need to have low detection limits and high sensitivity to be of 
clinical use. However, all sensing devices needs to be robust, repro-
ducible, accurate, scalable and cost-effective in order to be consid-
ered commercially (Mohammed et al., 2015).
4.3  |  Integration of lab-on-chip devices
Biosensor components need to be integrated into a device that al-
lows simultaneously sample and reagent load, and signal detection 
in	an	automated	form,	called	lab-on-chip	(LOC).	LOC	is	an	analytical	
device which is capable to scale down laboratory functions to a chip 
format up to a range of a few square centimetres (Panda & Pyarajan, 
2014).	 Usually	 LOC	 systems	 contain	microfluidic	 channels	 for	 the	
transportation of the sample. In addition to the microfluidic system, 
several	functionalities	are	combined	on	a	LOC	system	according	to	
the analytical problem. The most important features integrated into 
analytical	LOC	systems	are	sample	preparation,	separation	and	a	de-
tection system (Wongkaew et al., 2019).
The	 integration	 of	 biosensors	 into	 LOC	 devices	 has	 been	 re-
viewed	elsewhere	(Chen	&	Shamsi,	2017;	Luka	et	al.,	2015;	Nikoleli	
et	al.,	2018).	However,	 it	 is	 important	 to	understand	 that	LOC	 for	
diagnostic purposes demand merging nanomaterial, and knowledge 
in such diverse fields as microfluidics, engineering, chemistry, biol-
ogy and even electronics. This is extremely challenging in terms of 
product development, since the whole product needs to be scalable, 
reproducible and cost-effective, which includes studying of repro-
ducibility and robustness from nanomaterial production, to micro-
fluidic and signal detection integration.
The problem with many lab-on-a-chip devices are that such de-
vices require the use of supplementary equipment such as fluidic 
pumps, power supplies and signal acquisition devices (microscopes, 
spectrometers, etc). Most of these devices are significantly larger 
than the lab-on-a-chip systems themselves, typically taking up a sig-
nificant volume of space on a laboratory bench, negating many of 
benefits	 related	 to	 device	miniaturization.	Also,	 LOC	 technologies	
usually demands skilled users, which introduces complications re-
lated to user training and standardization protocols, hampering tech-
nology commercialization (Mohammed et al., 2015).
4.4  |  Scalable production techniques
Many innovations can present complexity in the fabrication of individ-
ual components, and the complete device may require several highly 
specialized and labour-intensive manufacturing techniques. Fabricating 
such devices generally draws more on the skill and experience of an 
individual user, across several interactive process, rather than being 
something that can be streamlined into a single manufacturing process. 
Frequently, researchers strive to demonstrate innovative functionali-
ties at the trade-off of increased complexity and, ultimately, a reduced 
capacity for mass manufacturing (Mohammed et al., 2015). Many tradi-
tional fabrication methods used to create micro and nano scale struc-
tures do not translate well into large-scale production. Moreover, mass 
production backend processes and quality control can add up to 80% of 
total fabrication costs (Becker, 2009). Therefore, high complexity is not 
desirable for industry settings, because it usually means cost increment.
4.5  |  Future Perspectives
Nanomaterial-enhanced	biosensors	have	indeed	offered	great	con-
tributions towards addressing diagnostic challenges. However, if the 
aim is to have commercial exploitation, researchers should opt for 
fabrication techniques that are readily up-scalable, using designs 
which minimize the complexity and process stages required for 
backend processing. In addition to the design and fabrication, the 
choice of materials becomes crucial, not only with respect to the 
cost and desirable intrinsic material properties for the applications 
in question, but also the toxicity of these nanomaterial.
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It is imperative that future studies will investigate more the 
chip-to-chip variability and repeatability of use, to provide more 
statistically relevant results for the developed work, but to also 
aid manufacturers in determining the feasibility of producing a 
product using a particular design, fabrication technique or material 
(Mohammed et al., 2015). It is also important that future studies ad-
dress a real-world need, instead of characterizing the technology 
based in their analytical sensitivity.
The key to overcome the limitations of nanomaterial-enhanced 
sensors seems to be based in technology transfer, a process that 
should be taken into consideration since early stages of technol-
ogy development (Daniel & Alves, 2019). This process should bring 
together researchers with their industrial counterparts in order 
to achieve a delicate balance of functionality, cost, sensitivity and 
device complexity with how this will translate to the economies of 
scale for mass manufacturing.
5  |  CONCLUSION
Significant effort has been expended towards sensors and devices 
for health care. In a relatively short time (~two decades), biosensors 
have made remarkable progress in detecting markers for diseases. 
However, clinical diagnostics still offer challenges that biosensors 
are not yet able to fulfil. These challenges are related to diagnos-
tic performance, that demands robust, reproducible, precise, fast, 
sensitive and specific tests for quantitation of health biomarkers. 
And to a series of other diagnostic features that would significantly 
improve early diagnosis and treatment of several health conditions 
such as continuous monitoring, wearable and implantable capacity, 
multiplex detection and point-of-care characteristics.
Several different types of nanomaterial-enhanced sensors have 
been reviewed and discussed under the principles of detection and 
the shape of nanomaterial, demonstrating in which way they were 
capable to address current diagnostic sensors challenges. These 
sensors can detect low concentrations of analyte with short re-
sponse	 time.	 Nanomaterial	 can	 come	 in	 shapes	 of	 NPs,	 NTs/NW,	
nanosheets,	 NR,	 QDs	 or	 some	 combinations	 thereof.	 Detection	
outputs	 can	be	either	electrical,	 optical	or	mechanical.	Optical	bi-
osensors exploit the reaction between analyte and ligand that pro-
duces luminescence that can be detected using various types of 
spectroscopy. Mechanical sensors detect adsorbed analyte based 
on their deflection and change in resonance frequency as a result of 
analyte binding. The emergence of micro/nanofluidics has enabled 
the integration of automated systems. In vitro sensors, for integra-
tion	 in	 LOC,	 using	 nanomaterial	 are	 expected	 to	make	 significant	
breakthrough in the near future given their remarkable sensitivity, 
real-time long-term monitoring of tissues and organs while also pro-
viding assistance with diagnosis and therapeutics. In vivo sensors, 
the wearable and implantable sensors, need to overcome several 
hurdles, the chief among them is the issue of toxicity, biofouling 
which affects the reliability of the implantable systems, and the risk 
of infection via foreign body reaction.
With continuing research further performance enhancement of 
existing nanodevices and newer nanomaterial-enhanced sensors, 
using novel methods of detection can be expected. The uniform 
quality of diagnostic devices is essential for widespread use in clin-
ical settings. In this regard, wide variety of available nanomaterial 
and the lack of standardized tests for toxicity evaluation or the ab-
sence of regulatory requirement for use in clinical settings is a hin-
drance to a quick widespread acceptance to these devices. Because 
of their multifunctionality (therapeutic, diagnostic and barrier avoid-
ing agents), there may be multiple federal agencies whose approval 
is needed leading to significant time requirement for ascertaining 
their	suitability	of	clinical	use.	Nanotechnology	will	play	an	import-
ant role for both in vivo and ex vivo analysis for imaging and detec-
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